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ABSTRACT 
The quest for the processing of glass scaffolds that remains amorphous upon sintering 
while maintaining a fast dissolution and conversion to hydroxyapatite rate is growing. 
Therefore; glasses within the borosilicate borophosphate and phosphate family were 
sintered into 3 dimensional (3D) porous scaffolds using 60 and 70 vol. % NH4(HCO3) 
as a foaming agent. In this work the sintering ability of (borosilicate S53B50), 
borophosphate (P40B10) and phosphate (Sr) bioactive glasses was investigated. The 
glass powders were crushed and sintered in air at a heating rate of 10°C/min for 2 
hours at sintering temperatures between 480°C-600°C. The density of the samples 
was found to decrease when the temperature was increased up to 580°C. To process 
highly porous scaffolds with porosity required for scaffold applicable to tissue 
engineering, the powders were further mixed with 60 vol. % and 70 vol. % of NH4 
(HCO3) foaming agent. Meanwhile, the density of the samples sintered with NH4 
(HCO3) was found to decrease with an increase in NH4 (HCO3) content. This indicates 
an increase in porosity of the samples. The glass compositions reached an open 
porosity of more than 60% at the addition of 70 vol. % NH4 (HCO3). The in vitro 
properties of the scaffolds investigated in SBF showed that Upon immersion; the pH 
of the solution containing the borosilicate scaffolds increased due to the typical non-
congruent dissolution of theses glass family leading to large Na+/H+ exchange and 
large alkaline and alkaline earth release. Borophosphate as well as phosphate 
scaffolds induced a decrease in pH upon dissolution attributed to the congruent 
dissolution of those materials and therefore; the large release of phosphorus within the 
media. The as prepared scaffolds showed a compressive strength of 1.29 ± 0.21, 1.56 
± 0.63, 3.63 ± 0.69 MPa for the samples borosilicate borophosphate and phosphate 
sintered with 60 vol. % NH4 (HCO3), respectively. From SEM/EDS, XRD and ICP-
OES analysis a clear precipitation of hydroxyapatite was reported on the borosilicate 
glass scaffolds. The borophosphate scaffold was found to be stable and to react at a 
slow rate. The crystallized phosphate glass; however was found to release very large 
amount of phosphate; compared to the amorphous glass; indicating preferential 
leaching of the phosphate rich crystal phase. Except for the borophosphate scaffolds; 
the mechanical properties dropped with increasing immersion time. 
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CHAPTER 1: INTRODUCTION 
1.1 Motivation 
 
The repair and regeneration of large bone defects from disease or trauma remains a 
significant clinical challenge. Tissue engineering and regenerative medicine aims to 
replace diseased or restore damaged tissue using combinations of functional cells and 
biodegradable scaffolds made from engineered biomaterials (Chen et al., 2008). At 
present, autografts and allografts are mainly used in the repair of defected bones. 
These grafts offered all the desired properties required for bone repair and 
regeneration, which are osteoconductivity, osteogenesis, and osteoinductivity.  
However, bone grafts are associated with high operating costs for harvesting the graft, 
limited availability, donor site morbidity and complications including infection, pain, 
and hematoma ((Burg et al., 2000),(Laurencin et al., 2006),(Hutmacher, 2000), 
(Tomford, 1995)) . On the other hand, allografts are subject to cleaning and 
preparation processes designed to remove cells to minimize immune response. In 
addition, these process techniques potentially reduce the osteoinductivity, 
osteoconductivity, and mechanical strength of the graft To overcome these 
limitations, significant effort has been devoted to the development of biomaterials as 
bone-graft substitute that can augment or regenerate bone, (Burg et al., 2000). This 
has led to the investigation of using bioactive glasses as the substitute biomaterial in 
bone regeneration. 
Porous bioactive glass scaffolds are of particular interest, if not critical, to bone tissue 
engineering. These scaffolds are designed to have features that provide the promotion 
of tissue ingrowth and transportation of nutrients (Hutmacher, 2000). With this said, 
an ideal scaffold should therefore possess the following characteristics (i) a highly 
porous structure with a good degree of interconnected pore network; (ii) 
biocompatibility and bioresorbability with controllable degradation and resorption 
rates to match cell/tissue growth in vitro and/or in vivo; (iii) suitable surface 
chemistry for cell attachment; proliferation and differentiation; (iv) mechanical 
properties to match those of the tissues at the site of implantation (Hutmacher, 2000). 
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1.2 Problem statement 
One major challenge in today’s bone tissue engineering application is the 
development of a scaffolding material that is mechanically strong and yet 
biodegradable. To engineer bone tissue which is hard and functions to support the 
body, the scaffold material must be strong and tough. Ideally the scaffold material 
needs to be biodegradable as the biodegradation would help avoid the detrimental 
effects of a persisting foreign substance and allow its gradual replacement with the 
new bone, (Chen et al., 2012). 
Unfortunately, it is known that mechanical strength and biodegradability contradict 
each other.  In general, mechanically strong materials (e.g., crystalline hydroxyapatite, 
titanium (Ti) alloys and crystalline polymers) are virtually inert and remain part of the 
repaired bone, while biodegradable materials (e.g. amorphous hydroxyapatite and 
glasses) tend to be mechanically fragile (Chen et al., 2012). In addition; glass is not 
the only material that is mechanically fragile but, in all cases, when creating a porous 
structure (regardless of the material) the mechanical properties will be decreased. 
Mechanical strength is limited by the largest defect. This forms the greatest challenge 
in the design of bioceramics for bone engineering at load bearing sites, but there are 
processing approaches such as sintering of 45S5 bioglass® , (Rezwan et al., 2006). 
During sintering; the 45S5 bioglass® particles fuse together through viscous flow 
resulting in a well densified compact which often increases the strength of the sintered 
material without loss of bioactivity. 
Another problem associated with bioactive glasses is the tendency to crystallize 
during freezing after melting which makes it difficult to create porous amorphous 
bioglass. Processing approaches such as sintering of 45S5 bioglass® have been 
developed (Chen and Boccaccini, 2006a). However, in all cases it was seen that the 
sintering led to partially or fully crystallized forms. The presence of the crystalline 
phases tends to retard the formation of the hydroxyapatite layer, hence, glass becomes 
less bioactive in simulated body fluid, (Filho et al., 1996). 
 
3 
 
1.3 Aim and Objectives 
The primary aim of this research work is to synthesize, test and characterize 
biocompatible glass using borophosphate, borosilicate and phosphate glasses for 
clinical use as a scaffold material. The objectives are to: 
1.  Determine the time-temperature conditions at which the glasses can be 
sintered without or with minor crystallization 
2.  Fabricate porous scaffolds with NH4(HCO3) foaming agent 
3. Test for bioactivity (simulated body fluid (SBF), layer formation, pH change) 
and mechanical and cell testing. 
The outcome of this research will provide information on the temperature at which 
sintering can take place without interfering with crystallization, the glass composition 
suitable for sintering will be established, the bioactivity of these glass composition as 
well as the mechanical properties will be determined.  
1.4 Scope of research 
This research involved the characterization of the crushed and milled glasses using 
particle size distribution (PSD), X-Ray Diffraction (XRD) and Scanning Electron 
Microscopy-Energy Dispersive Spectroscopy (SEM-EDS). The glasses were first 
sintered without the luminescent additives; the resulting sintered materials, were then 
characterized by density, XRD, Hg-Porosimetry, SEM-EDS and micro-computed 
tomography (µCT). If the experiments were successful, samples were prepared for 
biocompatibility testing at Technical University of Tampere (TUT), Finland. These 
tests would include: Bioactivity Testing (SBF, layer formation, pH change) and 
mechanical tests after immersion in simulated body fluid. 
1.5 Structure of the dissertation 
The outline of the dissertation is as follows: 
Chapter 2 presents a review on the background information on bioactive glasses, 
which includes the structure, synthesis, properties and applications of bioactive 
glasses. This section also includes previously published results for a wide range of 
bioactive glasses such as silicate, borate and phosphate glasses. 
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Chapter 3 gives a detailed discussion of the experimental equipment’s and techniques 
used to prepare and determine the physical and chemical properties of the starting as 
well as the sintered materials. 
All the results obtained on the preparation and sintering of the material with and 
without NH4 (HCO3) as well as the in vitro bioactivity of the porous scaffolds in SBF 
are listed and discussed in Chapter 4 and Chapter 5, respectively.  
Chapter 6 includes the conclusions drawn from the work and future work.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
5 
 
CHAPTER 2:  LITERATURE REVIEW 
In this chapter, glass is discussed based on its structure, synthesis, properties and 
applications as well as bioceramics and techniques used to fabricate porous scaffolds. 
The glasses of interest in this project are found in the SiO2-CaO-Na2O-P2O5 and P2O5-
CaO-Na2O systems with the incorporation of B2O3 and SrO to partially and fully 
substitute SiO2 and CaO, respectively. Although these glasses have similar structures, 
they all offer different properties that are desirable for various applications in tissue 
engineering (T.E). This section also includes previously published results for a wide 
range on bioactive glasses such as silicate, borate and phosphate glasses. Among the 
applications listed in the review, no porous bioglass devices have found clinical use to 
date, hence the need for new glass materials which can be processed into amorphous 
porous scaffolds. 
2.1 Discovery of Bioactive glasses 
The findings by Hench et al., (1971) in the early 1970s that some SiO2-CaO-Na2O-
P2O5 glasses induce no formation of fibrous tissue on contact with living tissue but 
rather bond chemically to it, aroused much interest in the development of bioactive 
glasses and glass ceramics, and their use as biomedical materials. Bio ceramics and 
bioactive glasses are a subset of biomaterials which are used in medical applications 
as scaffolds to repair and regenerate damaged bone tissue due to their similar 
chemical and structural properties as that of the body’s own bone mineral, hence they 
are biocompatible. 
According to Arstila et al., (2008), the main idea was that an implant made of 
bioactive glass would be quickly and firmly fixed with tissue, before encapsulation 
takes place and consequently would not necessarily require mechanical means of 
fixation nor a porous surface. This kind of fixation is possible due to kinetic 
modification of the glass surface that occurs upon implantation. The surface forms a 
biologically active hydroxycarbonate apatite (HCA) layer which provides a bonding 
interface for tissues. The HCA phase that forms on implants is chemically and 
structurally equivalent to the mineral phase in bone, (Arstila et al, 2008). It is this 
equivalence which is responsible for interfacial bonding, which is superior to that 
attained with for example, metal implants (Hench, 1991). The interface between the 
bioactive glass and bone is often so strong that removal of an implant necessitates 
6 
 
breaking the surrounding bone or in some cases, the implant, but not the interface 
(Rawlings, 1993). 
2.1.1 Glass structure of bioactive glasses 
There are three different components that exist within the glass structure; this includes 
the network formers (for example SiO2, P2O5 and B2O3); network modifiers (for 
example Na2O, CaO and SrO) and the intermediate oxides which can act as a network 
former or modifier (for example Al2O3, PbO). The network former is the essential 
component of the glass and is the oxide of an element with high valence, that is, able 
to form a three-dimensional (3D) glass structure (Vallet-regí and Balas, 2008). 
According to Zachariasen, (1932) an oxide glass may be formed (1) if the sample 
contains a high percentage of cations which are surrounded by oxygen in  tetrahedral 
coordination or by oxygen triangles; (2) if these tetrahedrals or triangles share only 
corners with each other and (3) if some oxygen atoms are linked to only two such 
cations and do not form further bonds with any other cations. This basically means 
that the glass must contain appreciable amounts of the cations which can form 
vitreous oxides or of other cations which are able to replace any of the former 
isomorphously. Some of the glass forming cations include B+3, Si+4 , P+3 , P+5 , As+3 , 
As+5, Ge+4, (Zachariasen, 1932). When adding modifiers to a glass network it is 
important that the cations must be large and carry a small charge because small and 
highly charged cations like Ti+4, Mg+2 tend to produce detrivification, (Zachariasen, 
1932). Modifiers such as Na+, K+, Ca+2 are known to have large cations and relatively 
small charges. 
The biological behaviour of glasses, glass ceramics and ceramics has been reported by 
Karlsson and Ylanen, (1998) to depend on the relative proportion of the bridging 
oxygen to non-bridging bonds in the phases of the material. The most important 
structural parameter which affects the dissolution of a glass is the network 
connectivity, (Hill, 1996). The network connectivity (NC) is defined as the average 
number of bridging oxygen (BO) atoms bound to a network-forming cation, where a 
BO atom is defined as an oxygen atom which is chemically bonded to two network 
polyhedra. Oxygen atoms which do not connect two network polyhedra are called 
non-bridging (NBO) atoms. The NC depends critically on composition because the 
inclusion of network-modifying cations such as sodium or calcium typically breaks T-
O-T bonds (where T is a network former), causing the formation of NBO and 
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decreasing the network connectivity, (Tilocca, 2009). High values of NC typically 
indicate a well-connected glass network which is not prone to dissolution and is not 
bioactive. Whereas lower values indicate a fragmented, disconnected network which 
has many reactive sites and is prone to dissolution and typically demonstrate 
bioactivity, (Jamieson et al., 2016). 
Glasses both bioactive and the conventional silica glass have two distinctive features, 
these include: their amorphous structure and their temperature behaviour, which 
shows a glass transition range (Tg), which is the temperature interval where a system 
transforms from a supercooled liquid to a solid glass (Brauer, 2015). The atomic 
arrangement of glass is characterized by an extended three-dimensional network 
which lacks symmetry and periodicity in contrast to crystalline solids (Figure 2.1a) 
(Zachariasen, 1932). 
 
         
Figure 2-1: Structure of (a) Crystalline and (b) vitreous silica (only three oxygen 
atoms are shown per SiO4 tetrahedron; with the fourth lying above or below the 
image plane) (Zachariasen, 1932) 
2.1.2 Synthesis of Bioactive glass 
Bioactive glasses have been synthesized by the melt or sol gel processes (Jones et al., 
2010).The original bioactive glass was melt derived ( 46.1 mol.%, SiO2, 24.4 mol.%, 
Na2O, 26.9 mol.%, CaO, 2.6 mol.%, P2O5) and was named bioglass
® 45S5 (Hench, 
1973). Melt derived silicate glasses are made by melting oxide components in a 
crucible at temperatures above 1100⁰C (where exact temperature depends on the glass 
composition) and pouring into a mould (casting a shape) or quenching into water 
(making a frit or powder).  
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On the other hand, sol-gel derived glasses are synthesized by the hydrolysis of 
alkoxides to form a sol, which is a colloidal silica solution (Hench et al., 
1990),(Sepulveda et al., 2002). This process is presented in Figure 2.2. A commonly 
used silica precursor is tetraethylorthosilicate (TEOS). Triethylphosphate is used to 
add phosphate and the salt calcium nitrate is usually used to introduce calcium. The 
silica species in the sol then undergo polycondensation to form a network of silica (Si-
O-Si bridging bonds) and is termed a gel. The gel is then heat treated to drive off the 
condensation by products of water and ethanol and to remove the nitrates (Brinker et 
al., 1990). Sol-gel-derived bioactive glasses tend to be more bioactive and degrade 
more rapidly than melt-derived glasses of similar composition due to their 
mesoporous texture (pore diameters in the range 2 – 50 nm) which is inherent to the 
sol gel process (Sepulveda et al., 2002). In addition, this textural porosity also 
increases the specific surface area by two orders of magnitude as compared to a melt 
derived glass. 
                                
Figure 2-2: Flow diagram of the process for sol-gel bioactive glass synthesis 
(Jones, 2007a)  
 
The difference between these two processes lies in the SiO2 content. Melt-derived 
glasses often contain 60 mol.% or less SiO2 in order to be able to bond to bone, while 
sol-gel processed glasses can contain up to 100 mol.% SiO2 and still be bioactive 
(Jones , 2007a). 
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2.1.3 Surface reactivity of bioactive glasses 
When bioactive glasses are immersed in any physiological environment (e.g. body 
fluids), their unique surface reactivity leads to the formation of a hydroxycarbonate 
apatite layer. This is the result of the release of soluble ions when the glass starts to 
dissolve. Among the ions which are released Si, Ca, P and Na are included. These 
ions have been found to induce favorable intracellular and extracellular responses 
leading to rapid bone formation (Xynos et al., 2000). The various surface reactions 
which occur at the bioactive glass surface upon immersion in the body fluid have been 
described extensively by Larry Hench and are described in Table 2.1  (Hench, 1974) , 
(Hench, 1993) 
Table 2-1: Sequence of interfacial reactions involved in forming a bond between 
bone and a bioactive glass (Hench, 1974),(Hench, 1998)  
Increasing  time 
(hours) 
Surface reaction 
stages 
 Reactions 
 
 
 
 
 
 
 
 
 
 
 
 
12 Proliferation and growth of bone 
11 Crystallization of matrix 
10 Generation of matrix 
9 Differentiation of stem cells 
8 Attachment of stem cells 
7 Action of macrophages 
6 Biochemical adsorption of growth 
factors on HCA layer 
5 Crystallization of the HCA layer 
4 Chemisorption of amorphous Ca + PO4 
+ CO3 
3 Silica-gel polymerization: SiOH + 
SiOH       Si-O-Si 
10 
 
 
 
 
 
Log t  
2 Network dissolution and formation of 
silanol (SiOH) bonds 
1 Exchange of alkali ions with hydrogen 
ions from body fluids 
0 Surface of bioactive glass 
 
The five important reaction stages which lead to the rapid release of soluble ionic 
species and formation of the HCA layer are further elaborated below: 
Stage 1: Rapid exchange of Na+ and Ca2+ with H+ or H3O
+ from solution causing 
hydrolysis of the silica groups, which creates silanols (Si-OH), e.g: 
Si-O-Na+  + H+ + OH-  Si-OH- + Na+ (aq) + OH
-                                      2.1 
Ion exchange diffusion is controlled with a  t1/2 dependence. The pH of the solution 
increases as a result of the H+ ions in the solution being replaced by cations. 
Stage 2: Stage 1 increases the hydroxyl concentration of the solution, which leads to 
attack of the silica glass network. Soluble silica is lost in the form of Si (OH4) to the 
solution, resulting from the breaking of Si-O-Si bonds and the continued formation of 
Si-OH (silanols) at the glass-solution interface: 
Si-O-Si + H2O  Si-OH
- + OH--Si                                                                 2.2 
Stage 3-5: Condensation and repolymerization of the Si-OH groups then occurs, 
leaving a silica-rich layer. The surface is, therefore depleted in alkalis and alkali-earth 
cations (Stage 3). Ca2+ and PO4
3- groups then migrate to the surface through the silica-
rich layer and from the surrounding fluid, forming film rich in CaO-P2O5 on top of the 
silica-rich layer (Stage 4). The CaO-P2O5 film crystallizes as it incorporates OH
- and 
CO3
2- anions from solution to form a mixed HCA layer.          
The formation of such a bioactive apatite layer is the common characteristic of all 
known bioactive inorganic materials used for bone replacement, orthopaedic implants 
and bone tissue engineering scaffolds (Hench, 2002), (Gerhardt and Boccaccini 2010). 
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2.2 Properties of Biomaterials 
2.2.1 Biocompatibility 
 
One of the most critical properties of any biomaterial is its biocompatibility, which 
according to Williams, (1989) is ‘the ability of a material to perform with an 
appropriate host response in a specific application’. The range of biocompatibility of 
biomaterials is based on their chemical reactivity with the physiological environment. 
This range includes oxides which are bioinert, bioactive and bioresorbable. Bioinert 
refers to any material which does not elicit any response or interact with the 
surrounding tissues when placed in a biological environment, common examples 
include Al2O3 and ZrO2, (Yamamuro, 2004); whereas bioresorbable are materials 
which dissolve upon implantation and slowly degrade as the new tissues are being 
formed; examples include Ca(PO4)2 and PLGA copolymers. In addition to that, the 
bioactivity of biomaterials in the SiO2-CaO-Na2O-P2O5 system differs depending on 
their specific composition. It should be noted that, there is a close relationship 
between the bioactivity and biocompatibility of a material. The ternary system shown 
in Figure 2.3 shows the different classes in which biomaterials can exist. Bioactivity 
index (IB), on the other hand, is defined as the time taken for more than half of a 
material’s interface to bond to bone. Materials with an IB value greater than 8 (see 
Figure 2.4) are considered to be Class A. These materials are expected to bond to soft 
tissues. Bioglass® is a typical known Class A bioactive material. Meanwhile materials 
exhibiting an IB less than 8 but greater than 0 are considered Class B bioactive 
materials, e.g synthetic hydroxyapatite (sHA), which will only bond to hard tissue, 
(Jones, 2007a). The difference between the two classes is that Class A bioactive 
materials are both osteogenic and osteoconductive while class B bioactive materials 
exhibit only osteoconductivity (Chen et al., 2008).  
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Figure 2-3: Compositional diagram for bone-bonding. Note regions A, B, C, and 
D. Region S is a region of class A bioactivity where bioactive glass bond to both 
bone and soft tissues and are gene activating (Hench, 2006) 
2.2.2 Bioactivity 
To assess the bioactivity of a material, Hench proposed an in vivo bioactivity index IB 
(Figure 4), which is defined as IB = 100/t50bb is the time required for more than 50% of 
the interface to be bonded (Hench, 1991) 
 
                                   
Figure 2-4: A ternary diagram showing IB as a function of composition A: 
bonding at 30 days or less; B: no bonding, reactivity too low; C: no bonding; 
reactivity too high; D: no bonding, no glass formation (Hench, 1991) 
 
 According to Huang, Best et al., (2007), the rate of bone bonding to implant and the 
strength and stability of the bond vary with the composition and microstructure of the 
bioactive materials. They further stated that bioactive glasses with 42-53% SiO2 form 
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a bond to bone very rapidly, within days, and also form an adherent bond with soft 
tissues. Whereas, bioactive glasses with 54-60% of SiO2 require 2-4 weeks to bond 
with bone, but do not bond with soft tissues. Generally, the higher the value of the 
bioactivity index of the material, the faster the rate of apatite formation on its surface 
and the better bonding with bone. Table 2.2 shows IB values for various Bioceramics. 
 
Table 2-2: IB values for various Bioceramics  
Bioceramic IB (100/t50bb) 
45S5 12.5 
Ceravital 5.6 
55S4.3 3.7 
HA 3.1 
Ceravital KGX, KGX’ 2.3 
316 S.S. Si3N4 0 
 
In order to study the behaviour of a material in vitro, various kinds of buffers have 
been introduced to deionised water to maintain the pH of the solution in the 
physiological range (7.2 - 7.4) and form physiological solution or pseudo-extracellular 
fluids (Huang and Best et al., 2007). Kokubo developed and named the solutions as 
simulated body fluid (SBF) K1 to K9 in ascending order of ion content and 
concentration (Kokubo et al., 1990). SBF K1 is equivalent to the tris buffer solution, 
containing no physiological cations, SBF K2 is physiological saline. However, it was 
suggested that SBF K9 was a suitable medium for initial in vitro study, as its ion 
concentration is close to those of human blood plasma (Table 2.3).  
Table 2-3: Comparison of the ion concentrations of SBF K9 with those of blood 
plasma (Kokubo et al., 1990) 
                                                    Concentration mM 
 SBF K9 Blood Plasma 
Na+ 142.0 142.0 
K+ 5.0 5.0 
Mg2+ 1.5 1.5 
Ca2+ 2.5 2.5 
Cl- 147.8 103.0 
(HCO3)
- 4.2 27.0 
(HPO4)
2- 1.0 1.0 
SO4
2- 0.5 0.5 
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Kokubo et al., (1990) further stated that the presence of Ca and P ions in SBF 
accelerated the repolymerization of silica on the glass, the formation of an amorphous 
Ca, P layer and the crystallization to hydroxycarbonate apatite (HCA). However, Mg 
ions in SBF were found to slow down both the formation of the amorphous Ca, P 
phase and the crystallization of HCA. 
2.2.3 Types of Bioceramics-tissue attachment 
The survivability of a bioceramic requires formation of a stable interface with living 
host tissue (Hench, 1998). The mechanism of tissue attachment is directly related to 
the type of response at the implant interface (Gross et al., 1988). No material 
implanted in living tissues is inert; all materials elicit response from living cells. 
There are four types of response shown in Table 2.4 that allow different means of 
achieving attachment of prostheses to the musculo-skeletal system, whereas Table 2.5 
summarises the attachment mechanisms 
Table 2-4: Types of Bioceramics-tissue attachment 
 
If the material is toxic, the surrounding tissue dies. 
If the material is nontoxic and biologically inactive (almost inert), a fibrous tissue of 
variable thickness forms. 
If the material is nontoxic and biologically active (bioactive), an interfacial bond 
forms. 
If the material is nontoxic and dissolves, the surrounding tissue replaces it. 
 
Table 2-5: Types of bioceramic tissue attachment and bioceramic classification 
_____________________________________________________________________ 
Type of attachment                                                                        Type of bioceramic 
Dense, nonporous, almost inert ceramics attach by bone                   Al2O3, ZrO2 
growth into surface irregularities by cementing the devices 
into the tissue, or by press-fitting into a defect (morphological  
fixation). 
 
15 
 
For porous implant, bone ingrowth occur which mechanically          Porous 
hydroxyapatite 
attaches the bone to the material (biological fixation)                        HA-coated porous 
metals          
 
Surface-reactive ceramics, glasses, and glass ceramics                       Bioactive glasses 
Attach directly by chemical bonding with the bone (bioactive           Bioactive glass-
ceramics 
fixation).                                                                                               Dense HA 
 
Resorable ceramics and glasses in bulk or powder form                     Bioactive glasses 
Designed to be slowly replaced by bone.                                             Tri-Calcium 
Phosphate 
                                                                                                              Calcium 
Phosphate salts 
                                                                                   Calcium Sulfate (Plaster of Paris) 
 
2.3 Porous Bioceramics 
The concept of porous bioceramic is driven by the need for ingrowth of tissues into 
pores on the surface and throughout the implant (Hench, 1998). This was originated 
by Hulbert et al., (1987) many years ago. These porous structures provide an 
increased interfacial area between the implant and the tissues which results in an 
increased resistance to movement of the device in the tissue. The interface is 
established by the living tissue in the pores. This type of attachment is referred to as 
biological fixation. Biological fixation is capable of withstanding more-complex 
stress states than implants that achieve only morphological fixation. However, the 
limitation associated with porous implants is that, for the tissue to remain viable and 
healthy, pores must be >100-150 µm in diameter. Such large pores are required to 
provide a blood supply to the ingrown connective tissue and allow cell migration 
(Hench, 1991). Vascular tissue which is required to circulate body fluids does not 
appear in pores that are <100 µm. It is also important to note that, if micromovement 
occurs at the interface of a porous implant the surrounding tissue may be damaged. In 
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turn this will cut off the blood supply leading to tissue necrosis, inflammation, and 
loss of interfacial stability (Hench, 1998). 
2.4 Fabrication techniques for porous scaffolds 
For a given bioactive glass scaffold, the porosity, pore size and pore interconnectivity 
are critical parameters. Generally, an ideal bone tissue scaffold should possess an 
interconnected porous structure (it should be highly permeable), with porosity >90% 
and pore diameters in the range of 10- 500 µm for cell seeding, tissue ingrowth and 
vascularization, as well as for nutrient delivery and waste removal (Chen et al., 
2006b); (Yang et al., 2001); (Karageorgiou et al., 2005). Locs et al., (2013) studied 
the preparation of porous ceramics by viscous slurry foaming using hydroxyapatite 
powder and ammonium hydrogen carbonate as the foaming agent for the generation 
of pores in the glycerol-based viscous ceramic slurry. Open and total porosity were 
found to increase from 25 to 69% and from 32 to 73% when NH4 (HCO3) was varied 
from 0 to 2.75 wt. %. The sintered ceramics were found to have well-connected and 
irregularly shaped pores.  
 
Meanwhile (Kazutaka et al., 2009) produced highly porous alumina based ceramics 
by incorporating polymethymethacrylate (PMMA) microspheres with different 
diameters as a template and MgO or SiC powder as a sintering aid and subsequent 
calcinations at 1600°C. The sintered ceramics formed spherical pores which 
correlated to the morphology of the PMMA microspheres. Highly porous and 
mechanically strong alumina-based ceramics having an open porosity of 62%; a 
connected space size of 1.3µm, and a compressive strength of 147.6 MPa were 
fabricated by incorporating PMMA microspheres with a mean particle size of 22.6µm 
and an appropriate amount of SiC. 
 
A large number of techniques have been developed to fabricate scaffolds with the 
desired properties. Some of the techniques include thermal bonding of particles or 
fibres, direct foaming, foam replication, gel-casting, sol gel or sacrificial porogens 
which are known for producing scaffolds with large interconnected pores. Table 2.8 
shows some of the methods used to create bioactive glass scaffolds.  This section 
summarizes the potential of these techniques as well as their draw backs.  
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Table 2-6: Methods used to create bioactive glass scaffolds, and characteristics of 
the fabricated scaffolds. (Rahaman et al., 2011) 
Method Glass Porosity 
(%) 
Pore size 
(µm) 
Strength 
*(MPa) 
Thermal bonding  of     
Particles 13-95 40-45 100-300 22 ± 1 
Short fibers 13-93 45-50 >100 5 
Polymer foam replication 45S5 89-92 510-720 0.4 ± 0.1 
 13-93 75-85 100-500 11 ± 1 
 13-93B3 80-85 100-500 5 ± 0.5                
Sol-gel foam 70S30C 82 500(100)* 2.4 
Unidirectional freezing of 
suspension 
13-93 53-57 90-110 25 ± 3 
 13-93 50-55 60-120 27 ± 8 
 13-93 50 50-150 47 ± 5 
Solid freeform fabrication     
Selective laser sintering 13-93 58-60 700-1000 15 ± 1 
Freezing extrusion 
fabrication 
13-93 50 300 140 ± 70 
Robocasting 6P53B 60 500 136 ± 22 
 
2.4.1 Direct foaming 
Direct foaming involves the incorporation of air or gas into a suspension or liquid 
media in order to keep the structure of the air bubbles created and dried. The 
consolidated foams are then sintered at high temperatures to obtain high-strength 
porous ceramics (Studart et al., 2006); (Ohji et al., 2012). This technique allows low-
cost and easy production of highly porous ceramic materials, up to more than 95% 
porosity (Ohji et al., 2012). Additionally, porous ceramics with unidirectional 
channels have been developed recently by using continuous bubble formation in 
ceramic slurry (Song et al., 2008); (Banno et al., 2009). The total porosity of directly 
foamed samples is proportional to the amount of gas incorporated into the suspension 
or liquid medium during the foaming process. The pore size, on the other hand, is 
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determined by the stability of the wet foam before setting takes place (Studart et al., 
2006). However, wet foams are thermodynamically instable systems which can 
undergo Ostwald ripening and coalescence in order to reduce the Gibbs free energy of 
the system resulting in large pores in the final porous bodies (Studart et al., 2006); 
(Ohji et al., 2012). 
The most critical issue on direct foaming methods is the approach used to stabilize the 
air bubble incorporated within the initial suspension or liquid media. To overcome the 
problem associated with the unstable nature of the wet foams, surfactants such as lipid 
and proteins have been introduced into the suspension. This surfactant slows down the 
coalescence and disproportionation of bubbles by adsorbing at the air bubble interface 
and reducing the air-water interfacial energy. Despite the efforts, the low adsorption 
energy of the surfactants at the gas-liquid interface cannot prevent the long-term 
destabilization of foams. This is because wet foams stabilized with long-chain 
surfactants collapse within a few minutes after foaming, whereas those stabilized by 
proteins exhibit bubble disproportionation within few hours. Therefore, direct 
foaming based on surfactants require a setting agent to consolidate the foam 
microstructure before extensive coalescence and disproportionation take place 
(Studart et al., 2006). 
2.4.2 Foam replication  
The replica technique is based on the immersion of a cellular structure or foam in a 
ceramic suspension or precursor solution in order to produce a macro porous ceramic 
exhibiting the same morphology as the original porous material (Studart et al., 2006). 
Various synthetic and natural cellular structures can be used as templates. In addition, 
the templates need to have adequate flexibility, shape recovery ability and 
homogenous open cell structure. The most frequently used synthetic template includes 
porous polymeric sponge such as polyurethane (Ohji et al., 2012). In the case were the 
suspension is produced from bioactive glass particles (e.g. bioglass®), the polymer is 
immersed in the suspension, which subsequently infiltrates the structure leading to a 
homogenous coating of bioglass® particles on the surface of the polymer substrate. 
After drying, the polymer is slowly burned out at high temperature (>450°C) in order 
to minimise microstructure damage (i.e. micro cracking) of the porous bioglass® 
coating (Chen et al., 2008). The glass is then sintered at high temperature for 
densification to occur.  
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Scaffolds derived through this method have one advantage over all the other 
fabrication methods which is the high porosity with large pore diameters. Various 
scaffolds 45S5, 13-93, 13-93B3 and 70S30C (Chen et al., 2006b), (Fu et al., 2010); 
(Fu et al., 2008), (Jones et al., 2006) have been prepared using this method and 
porosities in the range of 75 – 92 % (Table 8) have been achieved.  Additionally, 
(Chen et al., 2008) stated that porosity higher than 90% can be obtained with pore 
sizes ranging from 500 to 700 µm. Figure 2.5 shows the macroscopic pore structure of 
a Bioglass®-based glass ceramic scaffold fabricated by this technique. The pores are 
interconnected, which allows fluid to pass through the foams with relatively low 
pressure drop. However, due to cracking the struts during the pyrolysis, the 
mechanical properties of ceramic reticulated foams are generally poor (Ohji et al., 
2012). 
                                         
Figure 2-5: SEM image showing the pore microstructure of a bioglass® scaffold 
fabricated by the foam replica method (Chatzistavrou and Boccaccini, 2011) 
2.4.3 Sol gel process 
Porous bioactive glass scaffolds can be produced by adding a foaming step to the sol-
gel process. The hydrolysed sol can be foamed by the vigorous agitation in air with 
the aid of a surfactant. The surfactant lowers the surface tension and temporarily 
stabilizes the foam (Jones et al, 2009). This followed by condensation and gelation 
reactions. The sol gel foam process is shown in Figure 2.6, this process was used to 
produce porous scaffolds for glass 58S and 70S30C (see Figure 2.7) (Jones et al., 
2007b), (Jones and Hench, 2003), (Elizabeth et al., 2004). The gel is then subjected to 
aging and sintering to increase the strength and obtain the three-strengthen 
dimensional structure of the scaffolds; respectively. 
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Figure 2-6: A flow chart of the sol-gel foam process (Jones et al., 2009) 
 
                          
Figure 2-7: Microstructure of a bioactive glass foam scaffold produced through 
the sol-gel process (Jones et al., 2009) 
 
Scaffolds with a hierarchical structure consisting of mesopores (2 – 50 nm) for 
enhanced bioactivity and cell attachment and an interconnected array of macropores 
(10 – 500 µm) for tissue ingrowth can be achieved (Chen et al., 2008). This 
hierarchical pore architecture is considered to be beneficial for stimulating the 
response of the scaffolds to cells, because it mimics the hierarchical structure of 
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natural tissues and more closely stimulates a physiological environment (Fu et al., 
2011). 
Due to the inherent porosity that results from the sol-gel process, scaffolds derived 
from this process often have high surface area (100-200 m2/g); as a result, these 
scaffolds degrade and convert faster to HA than scaffolds obtained from melt-derived 
glass with the same composition. However, these sol-gel derived scaffolds have low 
strength (0.3 – 2.3 MPa) (Jones et al., 2006) and consequently they are suitable for 
substituting defects in low-load sites only (Fu et al., 2011). 
2.4.4 Thermally bonding of particles or fibres 
This is one of the simplest methods for forming a scaffold. In this process the scaffold 
is formed by thermally bonding a loose, random packing of particles or short fibres in 
a mold with the desired geometry (Brovarone et al., 2004); (Brovarone et al., 2006), 
(Fu et al., 2007). Bioactive glass scaffolds of 13-93 with porosity between 40 – 50% 
have been produced through this method. On the other hand, in order to increase the 
pore size and porosity of the scaffolds, the bioactive glass particles are often mixed 
with porogens (such as NaCl, or starch) which are removed by leaching or 
decomposition after forming the scaffold but prior to sintering. The major concern 
with this method is the poor pore connectivity between neighbouring pores. 
2.3.1 Porous bioactive scaffolds 
Bioactive scaffolds, which are important component in tissue engineering, are porous 
structures that act as substrate, upon which cells adhere and grow and organise into 
normal healthy bone as the scaffold degrades. The scaffold provides structural and 
mechanical support as well as the surface for cell growth. Its presence allows cells to 
generate the biological structural component of the extracellular matrix (ECM) in 
culture conditions (Sabree et al., 2015). On the other hand, scaffolds for bone tissue 
engineering are also subjected to many interlinked and often opposing biological and 
structural requirements, which are summarised in Table 2.6.  
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Table 2-7: Scaffold requirements for bone tissue engineering (Ma, 2004), (Salgado 
et al., 2004) , (Hench, 1991) 
 
1. Ability to deliver cells 
The material should not only be biocompatible (i.e. harmless), but also foster cell 
attachment, differentiation and proliferation. 
 
2. Osteoconductivity 
It would be best if the material encourages osteoconduction with host bone. 
Osteoconductivity does not only eliminate the formation of tissue encapsulation but it 
also brings about a strong bond between the scaffold and host bone. 
 
3. Biodegradability  
The composition of the material, combined with the porous structure of the scaffold, 
should lead biodegradation in vivo at rates appropriate to tissue regeneration. 
 
4. Mechanical properties 
The mechanical strength of the scaffold, which is determined by both the properties of 
the biomaterial and the porous structure, should be sufficient to provide mechanical 
stability to constructs in load bearing sites prior to synthesis of new extracellular 
matrix by cells. 
 
5. Porous structure 
The scaffold should have an interconnected porous structure with porosity >60% and 
diameters >100 µm for cell penetration, tissue ingrowth and vascularisation, and 
nutrient delivery. 
 
6. Fabrication 
The material should possess desired fabrication capability, e.g., being readily 
produced into irregular shapes of scaffolds that match the defects in bone of 
individual patients. 
 
7. Commercialisation potential 
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The synthesis of the material and fabrication of the scaffold should be suitable for 
commercialisation. 
 
One major drawback in the design of tissue engineering scaffolds is that most 
materials are not simultaneously mechanically competent and bioresorbable, i.e., 
mechanically strong materials are usually bioinert, while degradable materials tend to 
be mechanically weak (Karageorgiou et al., 2005). Hence, the fabrication of 
composites comprising biodegradable polymers and bioactive glass becomes a 
suitable option to fulfil the requirement of bioactivity, degradability and mechanical 
competence (Chen et al., 2008). 
 
2.3.2 Selection of biomaterials for scaffold fabrication 
As mentioned earlier, one of the requirements of a scaffold is biocompatibility; hence, 
the materials used for the applications in bone regeneration must be compatible with 
the natural bone. Natural bone is composed of organic collagen and hydroxyapatite, 
therefore it is vital to mimic the bone components by using biomaterials that possess 
similar characteristics. Typically ceramics, synthetic and natural polymers are the 
preferred materials. 
2.3.2.1 Bioceramics and bioactive glasses 
2.3.2.1.1 Hydroxyapatite (HA) and Tri-calcium phosphate (TCP) 
Due to their similarities in composition to bone ceramic scaffolds such as 
hydroxyapatite (HA) and tri-calcium phosphate (TCP) have been considered as 
scaffolds in bone regeneration applications. These scaffolds are typically 
characterized by high mechanical stiffness (Young’s Modulus), very low elasticity 
and a hard brittle surface. From a bone perspective, they exhibit excellent 
biocompatibility due to their chemical and structural similarity to the mineral phase of 
native bone (O’Brien, 2011). The interactions of osteogenic cells with ceramics are 
important for bone regeneration as ceramics are known to enhance osteoblast 
differentiation and proliferation (Hench, 1998); (Ambrosio et al., 2001). 
Unfortunately, the close similarity of hydroxyapatite to the mineral component of 
bone, which is stable in the body, results in lack of biodegradation of HA in the body, 
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which is generally an undesirable feature for tissue engineering scaffold materials 
(Chen et al., 2008). 
Bioactive glasses and glass-ceramics have also been used in bone repair applications 
and are being developed for tissue engineering application (Hench and Wilson, 1984); 
(Yamamuro et al., 1990); ( Hench, 1998),(Rahaman et al., 2006). Bioactive glasses 
have an amorphous structure, whereas glass-ceramics are crystallized glasses 
consisting of a composite of a crystalline phase and a residual glassy phase (Rahaman 
et al., 2011). 
 
2.3.2.1.2 Silicate bioactive glasses 
The bioactive glass designated 45S5 was the first original bioactive silicate glass 
discovered by Hench, (1973) which could bond to both hard and soft tissues. This 
glass is composed of oxides in the SiO2-Na2O-CaO-P2O5 system. A silicate glass is 
based on the three dimensional (3D) glass-forming SiO2 network in which Si is 
fourfold coordinated to O (Figure 2.8).  
                                                                
Figure 2-8: Tetrahedral unit of a silicate  
 
They key compositional features that are responsible for the bioactivity of 45S5 glass 
are its low SiO2 content (when compared to more chemically durable silicate glasses), 
high Na2O and CaO (glass network modifiers) content and high CaO/P2O5 ratio.  
Furthermore, silicate glasses with compositions in the system SiO2-Na2O-CaO-P2O5 
offer remarkable advantages due to their high bioactivity index (Class A), and their 
ability to bond to both soft and hard tissues (Hench, 1998). Class A materials are 
osteogenic and osteoconductive while Class B bioactive materials (such as HA) 
exhibit only osteoconductivity. Despite their excellent properties, glasses in this 
system, particularly bioglass® 45S5, has been found to crystallize rapidly during 
thermal treatment. This behaviour is caused by the small processing window between 
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its glass transition and the onset of crystallization temperature which prevents 
sintering by viscous flow of particles, which often results in the glass network not 
reaching its optimum densification. In order to sinter a glass by viscous flow sintering, 
the temperature must be well above Tg but below Tc onset. Bioactive glasses strongly 
exhibit surface nucleation crystallization and viscous flow sintering will be 
dramatically reduced if the glass crystallizes (Massera et al., 2012); (Fagerlund et al., 
2012a). This often leads to scaffolds with a low strength (Chen et al., 2006b). 
Additionally this makes it quite difficult to process 45S5 glass into porous 3D 
scaffolds. Porous bioactive glass scaffolds are generally prepared by various 
techniques which all incorporate heating (sintering) the glass particles to bond the 
particles into a strong glass phase containing an interpenetrating network of pores 
(Rahaman et al., 2011). 
 
While devitrification does not inhibit the ability of 45S5 glass to form an HA-like 
surface layer, it has the effect of reducing the rate of conversion to HA, (Filho et al., 
1996). Another limitation of 45S5 glass is its slow degradation rate and conversion to 
an HA-like material (Huang et al., 2006a); (Huang et al., 2006b) as this makes it 
difficult to match the degradation rate of the scaffold with the rate of new tissue 
formation (Rahaman et al., 2011). This is a vital characteristic of any bioactive 
scaffold to prevent any undesirable conditions during in vivo. 
 For this reason, various compositions have been developed to control the 
crystallization tendencies of bioactive glasses.  Network formers and modifiers such 
as B2O3, K2O, MgO, SrO etc. have been introduced into the SiO2-Na2O-CaO-P2O5 
over the years to control crystallization during thermal treatment as well as to enhance 
the bioactivity and mechanical properties of the glasses (Brink, 1997). 
One such bioactive silicate glass is 13-93, which is based on the 45S5 composition, 
but with higher SiO2 content and additional network modifiers such as K2O and MgO 
when compared to 45S5. Table 2.7 shows the compositions of some of the most 
widely studied bioactive glasses. Another distinguishing feature of the composition is 
the low phosphorus content (Sriranganathan et al., 2016). Studies by (O’Donnell et 
al., 2009) have shown that with increasing phosphorus content there is a faster apatite 
formation and a smaller pH rise. This is advantageous as it maintains the stability of 
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the internal environment and there is an increased bioactivity. However, 13-93 
degrades at a much slower rate than 45S5. 
Table 2-8: Compositions of various bioactive glasses (Rahaman et al., 2011) 
 
When comparing the processing window of the two silicate glasses, 13-93 has a larger 
gap between the glass transition and the onset of crystallization than 45S5, hence, 
porous scaffolds can be created and sintered without enduring any crystallization 
during heating (sintering) ( Fagerlund et al., 2012b). Therefore, this makes it easier to 
turn 13-93 into scaffolds for implantation in vivo (Brown et al., 2008). However, the 
huge processing window for 13-93 comes with a reduced bioactivity. (Watts et al., 
2010) showed the magnesium oxide extends the sintering window by inhibiting 
crystallization but the side effect is that it limits the bioactivity by reducing apatite 
formation. 
 
Another silicate bioactive glass that has been widely studied in the past years is glass 
S53P4 developed by (Anderson et al., 1990). It is commercially available as 
Bonalive® with a composition of 53SiO2-23Na2O-20CaO-4P2O5 in wt. % and is 
mostly used in the form of granules (0.8-3.15mm) but it can also be used in the form 
of nonporous plates or discs in various shapes , (Gestel et al., 2015) . The bioactivity 
of the silicate glasses in both 45S5 and S53P4 is related to their low silica content, 
which gives them a special reaction in biological solution, (Massera et al., 2013) and 
are able to convert slowly to HA. For this reason, S53P4 has been used in various 
clinical applications such as bone cavity filling in orthopaedic and cranio-
maxillofacial surgery (Kinnunen et al., 2000), (Peltola et al., 2006) . Additionally, 
S53P4 has shown the abilities to facilitate and stimulate bone formation and bone 
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defect healing and has an antibacterial effect in various applications (Jones, 2013). 
However, the conversion of S53P4 to HA is often incomplete when compared to 
45S5.  
To determine the crystallization mechanisms of glasses 45S5 and S53P4, a study was 
conducted by (Massera et al., 2012). According to their findings, S53P4 has shown to 
have a preference for surface crystallization whereas 45S5 had a more complicated 
mechanism which could not be described by the Johnson-Mehl-Avrami model. This 
could explain why S53P4 cannot be hot-worked without enduring crystallization. In 
another study by (McAndrew et al., 2013), S53P4 was used in the treatment of 
chronic osteomyelitis. According to (McAndrew et al., 2013), this is a destructive 
bone lesion caused by infecting pathogenic organisms. To achieve these, three 
patients who had previously undergone multiple debridements and antimicrobial 
regimes with no success were chosen. All tests required the patients to go through 
debridement and sequestrectomy procedures which involved the insertion of S53P4 
followed by antimicrobial regimes with the aim of isolating pathogens sensitivities. 
After a mean follow up of 17.3 months, they found that all haematological and 
biochemical parameters have returned to normal, pain has ceased and function has 
returned in affected limbs. Apart from these excellent results, there were no 
radiological evidence of osteomyelitis and S53P4 has integrated with the surrounding 
bone. 
2.3.2.1.3 Borate bioactive glasses 
Another class of bioactive glasses which have received much attention in recent years 
are the borate glasses, based on the composition of 13-93 but with SiO2 completely or 
partially substituted by B2O3. Examples include 13-93B1 and 13-93B3 as shown in 
Table 2.7. Due to their lower chemical durability, some borate bioactive glasses are 
able to degrade faster and convert more completely to an HA-like material, when 
compared to silicate 45S5 or 13-93 (Huang et al., 2006a); (Huang et al., 2006b), (Yao 
et al., 2007); (Fu et al., 2010a). The conversion of borate bioactive glass to HA appear 
to follow a process similar to that described for 45S5 glass, but without the formation 
of SiO2-rich layer (Huang et al., 2006a); (Huang et al., 2006b). Unfortunately, there is 
a concern associated with borate bioactive glasses which is the toxicity of boron 
released into the solution as borate ions, (BO3)
3- (Rahaman et al., 2011) . 
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Scaffolds of a borate bioactive glass, designated 13-93B3, with a composition 
obtained by replacing all the SiO2 in 13-93 glass (Table 2.7) were found to be toxic to 
murine MLO-A5 osteogenic cells in vitro (Fu et al., 2010b). However, when the same 
scaffold were treated in vivo, they did not show any toxicity to cells and supported 
new tissue infiltration implanted subcutaneously in rats (Fu et al., 2010b). 
Recent work has shown the ability to control the degradation rate of bioactive glass by 
manipulating its composition (Rahaman et al., 2011). For example, by partially 
replacing the SiO2 in silicate 45S5 or 13-93 glass with B2O3 (yielding a borosilicate 
bioactive glass), or fully replacing the SiO2 with B2O3 (producing a borate glass), the 
degradation rate can be varied over a wide range (Huang et al., 2006a); (Huang et al., 
2006b), (Yao et al., 2007). However, it should be noted that the bioactivity of any 
glass depends on its composition; therefore, it is essential to avoid drastic changes to 
the glass composition to ensure that the glass degradation and bone regeneration rate 
still matches.  
2.3.2.1.4 Phosphate bioactive glasses 
Apart from silicate glasses which are well recognised for their applications in bone 
regeneration, phosphate glasses in the P2O5-CaO-Na2O system have been found to be 
potential replacement of silicate glasses as they are not only good alternative in bone 
repair and reconstruction (Massera et al., 2015a) and their compositions can be 
tailored to possess low melting temperature, high concentrations of rare and other 
metal ions (Gapontsev et al., 1982);(Ahmed et al., 2011). Phosphate glasses are 
recognised for their high solubility in aqueous media giving them the potential of 
being used as resorbable materials. In addition, phosphate glasses have also proved to 
be simple, easy to produce, biodegradable and biocompatible with many human 
connective tissues (Elwan et al., 2014). Phosphates are common in nature because 
phosphorus also has an affinity to oxygen. Their tetrahedral unit, PO4, is shown in 
Figure 2.9. 
                                                                        
Figure 2-9: Tetrahedral unit of a phosphate 
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The PO4 unit is distinguished from the SiO4 unit by the double bond which results 
from the oxygen atoms that are not shared between the phosphates tetrahedral but are 
shared by the two unpaired electrons with the P5+ ions (Neel et al., 2009).  
Additionally, when comparing vitreous phosphorus to silica, vitreous phosphorus 
tends to be chemically unstable however, the addition of modifying oxides does not 
disrupt the glass network as it does with the silica but, interestingly improves its 
stability (Neel et al., 2009). This is due to the P-O-M+ (when M = metal cation)   
bonds which are generally more stable towards atmospheric hydrolysis in contrast to 
the hydrolysis of P-O-P alone (Bae et al., 1991). This led to the incorporation of 
modifying oxides such as SrO to the P2O5-CaO-Na2O system to substitute CaO. Not 
only is Sr a naturally occurring trace element in the body (Isaac et al., 2011), but it 
often acts similarly to Ca in the human body; both have strong bone-seeking 
properties, and Sr can be substituted with Ca in the apatitic phase of bone mineral 
(Vaughan, 1981). This is also attributed by the fact that, they are both network 
modifier and have similar coordination number; hence, they are expected to have the 
same effect in the glass structure (Massera et al., 2013).                                
Studies have been carried out to demonstrate the behaviour of bioactive glasses in the 
SiO2-Na2O-CaO-P2O5 and P2O5-CaO-Na2O systems by substituting SiO2 and CaO 
contents with B2O3 and SrO, respectively.  
The substitution of CaO with SrO was due to its beneficial effects on bone healing. 
For example, strontium renelate has proved to be an effective treatment against 
osteoporosis in postmenopausal women, acting via a mechanism combining the 
inhibition of bone resorption within the simulation of new bone tissue formation. 
Evidence has also shown that strontium is able to inhibit osteoclast differentiation 
(Santocildes-romero et al., 2015) and can have a positive impact on preventing caries 
(Curzon, 1985). Additionally strontium is the only known element which can correlate 
to an increase in bone compression strength. A few studies have reported the effects 
of strontium-substituted bioactive glasses. Goel et al., (2011) reported that up to 10 
mol. % of SrO substituted for CaO decreased significantly the apatite forming ability. 
However, (Fredholm et al., 2012) demonstrated that full substitution of SrO for CaO 
allows for enhanced apatite formation.  
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In a recent study by (Massera et al., 2015b) to investigate the influence of SrO and 
CaO in silicate and phosphate bioactive glasses on human gingival fibroblasts; SrO 
was added to both silicate and phosphate glasses with nominal compositions of 
53.85SiO2-22.66Na2O-1.72P2O5-(21.77-x) CaO-xSrO with x ranging from 0 to 10 
and; 50P2O5-10Na2O-(40-x) CaO-xSrO where x varied from 0 to 40; respectively. 
These glasses were immersed in the culture medium with and without cells and their 
behaviour in the cell culture was correlated to their SrO content. From their finding; 
SrO gave a faster initial dissolution in the cell culture medium for the silicate glasses. 
This is attributed by the expansion of the network as a result of SrO. Additionally, the 
formation of hydroxyapatite layer started earlier for the SrO-containing glasses in 
comparison to the SrO-free glasses. Consequently, the SrO-containing silicate glass 
led to a slight enhancement in the activity of the gingival fibroblasts cells when 
compared to the SrO-free reference glass, S53P4. 
In contrast to the silicate glasses, SrO was found to decrease the dissolution process in 
the phosphate glasses as a result of a more cross linked network. The mass loss for the 
SrO-free glass was much greater than for the SrO-containing glasses. Although the 
SrO-free phosphate glass had a fast dissolution, it did not provide a good substrate for 
the CaP surface to attach. As a result, the human gingival cells to, did not attach to 
and proliferate at the SrO-free glass. This results shows that strontium does indeed 
have bone healing abilities. 
Meanwhile, the B2O3-containing bioactive glasses have also attracted much interest in 
the past years for potential biomedical applications in tissue engineering as scaffold 
materials due to their low chemical durability, faster and ease to completely convert to 
hydroxyapatite when they are immersed in simulated body fluid (Day et al., 2003). In 
addition, it has also been shown that the ratio between tetrahedral and trigonal boron 
species can influence the mechanical strength of a glass system owing to the fact that 
boron speciation plays a dominant role in controlling the fragility of the samples 
(Ciceo et al., 2014); (Zheng et al., 2012). 
In addition, several studies were conducted on the replacement of SiO2 with B2O3. 
The first investigation on the replacement of SiO2 with B2O3 was conducted by 
(Richard, 2000) on the 45S5B1 borate glass and found that the apatite (HA) layer 
formed more rapidly on the borate glass than on the 45S5 glass when the glasses were 
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immersed in dilute K2HPO4 solution at 37°C. Similar observations were made by 
(Huang et al., 2006a), they found that when the B2O3 content of the glass was 
increased, the conversion rate to HA was faster. 
 
2.3.2.2 Synthetic and Natural polymers 
A great deal of research effort has gone into developing synthetic polymers as tissue 
engineering scaffolds; such polymers include poly-l-lactic acid (PLLA), polyglycolic 
acid (PGA) and poly-dl-lactic-co-glycolic acid (PLGA). These materials have shown 
much success as they can be easily processed into desired configuration and their 
physical, chemical, mechanical, and degradative properties can be engineered to fit a 
particular need (Lu et al., 2000). However, one main concern for the use of these 
polymers in bone tissue engineering is that their intermediate degradation products 
(specifically, lactic acid and/or glycolic acid) by non-enzymatic hydrolysis of ester 
bonds in their backbone reduces the local pH, which in turn induces an inflammatory 
reaction and damages the bone cell at the implant site. Moreover, the rapid drop of pH 
in vivo may accelerate the polymer’s degradation rate, thus, resulting in premature 
loss of mechanical properties before new bone formation occurs (Liu and Webster, 
2006).  
Natural polymers have also been used as scaffold biomaterials. Natural polymers such 
as collagen, alginate and chitosan have all been used in the production of scaffold for 
tissue engineering. In comparison to synthetic polymer-based scaffolds, natural 
polymers are biologically active and typically promote excellent cell adhesion and 
growth. In addition, they are also biodegradable and allow host cells, over time, to 
produce their own extracellular matrix and replace the degraded scaffold. Despite that, 
fabricating scaffolds from biological materials with homogenous and reproducible 
structure presents a challenge. Also, the scaffolds generally have poor mechanical 
properties, which limit their use in, for example, load bearing orthopaedic applications 
(O’Brien, 2011). 
2.5 Mechanical properties of scaffolds for tissue engineering 
The clinical use of bioactive glasses particularly in load-bearing applications has been 
limited by their low fracture toughness and mechanical strength, especially in porous 
form (Rezwan et al., 2006). Currently, there is no clear design criteria for the 
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mechanical properties of scaffolds intended for bone repair, particularly those to be 
used in load-bearing defects (Fu et al., 2011). However, it is often stated that the 
scaffold should mimic the morphology, structure and function of bone in order to 
optimize integration with surrounding tissues (Hutmacher, 2000). The variability in 
the architecture and mechanical properties of bone, coupled with differences in age, 
nutritional state, activity (mechanical loading) and disease status of individuals, 
provide a major challenge in the design and fabrication of scaffolds for specific defect 
sites (Fu et al., 2011), although it is required that the scaffold should also be able to 
withstand stress induced during implantation. Bone is structurally classified into two 
parts: cortical bone also referred to as compact bone and trabecular bone, also referred 
to as cancellous or spongy bone. The mechanical properties of bone vary between 
subjects, from one bone to another and within different regions of the same bone 
(Rahaman et al., 2011). Table 2.9 summarises mechanical properties of both 
trabecular and cortical bones.  
Table 2-9: Mechanical properties of human bone 
 Compression 
strength 
(MPa) 
Flexural 
strength 
(MPa) 
Tensile 
strength 
(MPa) 
Modulus 
(GPa) 
Fracture 
toughness 
(MPa.m1/2) 
Porosity 
(%) 
Cortical 
bone 
100-150 135-193 50-151 10-20 2-12 5-10 
Cancellous 
bone 
2-12 10-20 1-5 0.1-5 0.1-0.8 50-90 
 
The mechanical properties of porous scaffolds depend on the composition of the 
biomaterial, microstructure and the fabrication technique. Table 8 presents the 
compressive strength of some of the most widely studied glass compositions along 
with the fabrication methods. From the results, bioactive glass scaffolds prepared by 
methods such as polymer foam replication, gel-casting and sintering of particles or 
short fiber typically have strengths comparable to that of human trabecular bone. 
Meanwhile scaffolds prepared from methods such as rapid prototyping and 
unidirectional freezing of suspensions have resulted in the creation of porous 
bioactive glass scaffolds with compressive strength and elastic modulus which are 
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comparable to, or approach the values for, human cortical bone. These scaffolds have 
potential in the regeneration of load-bearing bones (Rahaman et al., 2011). 
With this said, researches have conducted numerous work to improve the mechanical 
properties of glass based scaffolds. However, it is still known that the mechanical 
strength of these scaffolds decrease with porosity. (Liu et al., 2009) conducted a study 
on the improvement on the strength of bioactive borosilicate glass scaffolds for tissue 
engineering which were fabricated using the foam replication method and with pore 
sizes ranging between 200-500 µm. The compressive strength of the scaffolds had 
been found to increase with a decrease in porosity. The parameters of the scaffolds are 
summarized in Table 2.10 
Table 2-10: Parameters of scaffolds 
Sample Solid content 
(wt. %) 
Compressive strength of 
scaffolds (MPa) 
Porosity of 
scaffolds (%) 
1 56.8 0.8±0.2 86.7±2.2 
2 62.2 1.5±0.4 80.4±3.1 
3 66.4 4.6±0.8 73.3±2.8 
4 71.1 9.7±1.3 67.7±2.6 
 
A similar trend was observed by (Locs et al., 2013), they prepared porous ceramics by 
viscous slurry foaming using hydroxyapatite powder and ammonium hydrogen 
carbonate as the foaming agent for the generation of pores in the glycerol-based 
viscous ceramic slurry. The compressive strength of the porous ceramics was also 
found to decrease as a function of porosity. The results are shown in Figure 2.10. 
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Figure 2-5: Compressive strength as a function of porosity (Locs et al., 2013)  
 
Scaffolds for tissue engineering are commonly constructed from biodegradable 
polymers natural or synthetic (Hayashi, 1994), (Griffith, 2000) yet, the mechanical 
response of bone is not matched by these polymers. However, for the regeneration of 
load-bearing bones, the use of biodegradable polymer scaffold is challenging because 
of their low mechanical strength. Therefore, attempts have been made to reinforce the 
polymers with a biocompatible inorganic phase, commonly (HA), (Thomson et al., 
1998);( Rezwan et al., 2006). Although brittle, scaffolds fabricated from inorganic 
materials such as calcium phosphate-based bioceramics and bioactive glass can 
provide higher mechanical strength than polymeric scaffolds. 
2.6 Clinical Applications of Bioceramics 
Due to their brittleness, difficulty of shaping for implantation and the inability of new 
bone to sustain the mechanical loading needed for remodelling (Wang, 2003), 
bioceramics have limitations in certain clinical applications such as load-bearing 
situations. However, bioceramics still found use in applications such as dental surgery 
to fill bone defects and orthopaedic surgery to coat metallic implant surfaces to 
improve implant integration with the host bone. 
One of the most commonly used biomaterial in orthopaedic coating is synthetic 
hydroxyapatite (sHA) which is deposited on the surface through the plasma-spray 
method. This process uses a source material of sHA, the plasma-sprayed coatings are 
not pure but a mixture of crystalline calcium phosphates, of which approximately 95% 
is sHA, and an amorphous calcium phosphate (Tisdel et al., 1994). The presence of 
the amorphous phase increases the degradation rate of the material (Gross et al., 
1998). Although sHA has excellent biocompatibility and osetconductivity, it does not 
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resorb in the body and therefore it will not fulfil the criteria of an ideal tissue scaffold 
(Jones, 2007a). However, a successful porous sHA product is Apapore® (Apatech Ltd, 
Elstree, UK), which is a porous HA that has an interconnected macroporosity and 
some microporosity. Jones, (2007a) reported that it has been successfully used in 
impaction grafting for the cemented revision of failed total joint athroplasties, spinal 
fusions and bone defect treatment. 
Another commercial biomaterial that has been accepted in clinical applications is HA 
(Legeros, 2002). A porous bovine bone-derived HA graft is marketed under the name 
Bio-Oss® (Osteohealth Shirley, New York), which is an unsintered material and 
therefore has some resorbability in vivo (Valentini et al., 2000) and osteograft-NTM 
(CeraMed Co, Denver, CO) and EndobonTM (Merch CO, Darmstadt, Germany), 
which are sintered material. 
Bioactive glasses were the first biomaterials used in clinical applications. The first 
bioglass device was used in a middle ear surgery to treat conductive hearing loss by 
replacing the bones of the middle ear (Hench, 2006). The device was named the 
Bioglass® Ossicular Reconstruction Prothesis’ and trade named’ MEP®. This device 
offered an advantage over other devices that were in use at the time due to its ability 
to bond to soft tissue (tympanic membrane) as well as bone tissue. 
The second bioglass device which was accepted in clinical applications was 
Endosseus Ridge Maintanence Implant (ERMI®) which was designed to support labial 
and lingual plates in both natural tooth roots and to provide a more stable ridge for 
denture construction following tooth extraction (Hench, 2006). These devices were 
simple ones of 45S5 bioglass® that were placed into fresh tooth extraction sites. They 
bonded to the bone tissue and proved to be extremely stable, with much lower failure 
rates than other materials that had been used for that same purpose. Some of the 
current applications of Bioceramics are summarized in Table 2.11. However, up to 
date, there have been no reports on the clinical application of porous bioglass devices.     
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Table 2-11: Current uses of Bioceramics in various clinical applications (Hench, 
1998) 
Applications Bioceramics 
 
Orthopedic load-bearing applications 
Al2O3 
Stabilized zirconia 
PE-HA composite 
Coatings for chemical bonding (orthopedic;     
dental; and maxillofacial prosthetics) 
HA 
Bioactive glasses 
Bioactive glass-ceramics 
 
Dental implants 
Al2O3 
HA 
Bioactive glasses 
 
 
Alveolar ridge augmentations 
Al2O3 
HA 
HA-autogenous bone composite 
HA-PLA composite 
Bioactive glasses 
 
Otolaryngological 
Al2O3 
HA 
Bioactive glasses 
Bioactive glass-ceramics 
Artificial tendon and ligament PLA-carbon-fiber composite 
Artificial heart valves Pyrolytic carbon coatings 
Coatings for tissue growth (cardiovascular;      
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orthopedic; dental; and maxillofacial 
prosthetics 
Al2O3 
Temporary bone space fillers TCP 
Calcium and phosphate salts 
 
 
Periodontal pocket obliteration 
HA 
HA-PLA composite 
TCP 
Calcium and phosphate salts 
Bioactive glasses 
 
Maxillofacial reconstruction 
Al2O3 
HA 
HA-PLA composite 
Bioactive glasses 
 
Percutaneous access devices 
Bioactive glass-ceramics 
Bioactive glasses 
HA 
Orthopedic fixation devices PLA-carbon fibers 
PLA-calcium phosphate-based  
glass fibers 
Spinal surgery Bioactive glass-ceramic 
HA 
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CHAPTER 3: METHODOLOGY 
This chapter of the dissertation discusses the experimental procedures used to achieve 
the objectives of the project. Various experiments were performed to determine the 
optimum conditions at which the glasses could be sintered without or with minor 
crystallization as well as achieve the required porosity for scaffold use. These 
optimum conditions were dependent on the following factors; sintering temperature, 
holding time, heating rate, volume content of NH4 (HCO3) used in this dissertation as 
foaming agent. The work in this project was done in four stages which involved 
sintering with and without NH4 (HCO3), followed by biocompatibility tests and 
mechanical tests. 
3.1 Materials and chemicals 
The materials that were required for the successful completion of this project are 
listed in Table 3.1 and Table 3.2 below. The Tables also include the suppliers from 
which the materials were obtained. 
Table 3-1: Supplier of all glass materials used in this project 
Glass name Chemical composition Supplier 
S53B50 26.93SiO2-26.93B2O3-22.66Na2O-
1.72P2O5-21.77CaO 
 
Tampere University of 
Technology, Finland P40B10 40P2O5-10B2O3-20CaO-20SrO-10Na2O 
Sr 50 P2O5-20SrO-10Na2O 
 
Table 3-2: Supplier of all chemicals used in this project 
Material Supplier 
Ammonium 
bicarbonate  
NH4(CO3) 
Sigma Aldrich (Pty) Ltd. 
PEG  Sigma Aldrich (Pty) Ltd. 
Dolapix CE 64 Zchimmer and Schwarz, GmbH & Co KG, 
chemischefabriken.       Lahnstein, Germany 
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3.2 Glass and powder preparation 
3.2.1 Synthesis 
The starting materials for the borosilicate glass designated S53B50 were analytical 
reagent grades of Na2CO3, H3BO3, CaCO3, CaHPO4.2H2O and 99.4% pure SiO2, 
while the borophosphate and phosphate glasses designated P40B10 and Sr 
respectively were prepared using NaPO3, H3BO3, SrCO3, CaCO3 and (NH4)2HPO4 as 
raw materials. Ca(PO3)2 and Sr(PO3)2 were used as precursors for the phosphate 
glasses and were prepared independently using a slow heating rate up to 900°C. 
The three nominal glass compositions studied are given in Table 3.3. Glass S53B50 
had a nominal oxide composition of 26.93SiO2-26.93B2O3-22.66Na2O-1.72P2O5-
21.77CaO, while glass P40B10 and Sr had a nominal composition of (50-x) P2O5-
xB2O3-20CaO-20SrO-10Na2O; where x = 0 (Sr) or 10 (P40B10). Proportions of 
relevant oxides of the starting materials were mixed together in a platinum crucible 
and melted at 1250°C for glass S53B50 and 1100°C for glass P40B10 and Sr for 1 
hour. The melt was poured onto a graphite mould and annealed at 40°C below their 
respective Tg to release internal stresses; and allowed to slowly cool down to room 
temperature in the annealing furnace. The obtained glass ingots were then crushed 
using a metallic mortar and pestle for 1 hour and sieved. 
Table 3-3: Composition of S53B50, P40B10 and Sr glasses presented in (mol. %) 
Composition (mol. %) S53B50 P40B10 Sr 
SiO
2
 26.93 0 0 
Na
2
O 22.66 10 10 
CaO 21.77 20 0 
B
2
O
3
 26.93 10 0 
P
2
O
5
 1.72 40 50 
SrO 0 20 40 
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3.2.2 Milling  
The crushed powders were charged in a tungsten carbide grinding bowl (76 mm) and 
milled in a planetary ball mill (Fritsch Pulverisette 6) using alumina balls (2 mm 
diameter) for 1 hour at 150 rpm, with distilled water as a grinding media. The charge 
to ball ratio was kept at 1:1. Dolapix C64 and PEG (polyethylene glycol) were added 
at 3 wt. % to the mixture as a dispersant and binder respectively. In this mill 
operation, the grinding balls and material in the grinding bowl were acted upon by the 
centrifugal forces due to the rotation of the grinding bowl about its own axis and the 
rotating supporting disc. The grinding bowl and the supporting disc rotate in opposite 
directions (shown in Figure 3.1) and this results in (1) a frictional effect, were the 
grinding balls run along the inner wall of the grinding bowl and (2) an impact effect, 
were the balls impact against the opposite wall of the grinding bowl (Operating 
Instructions Planetary Mono Mill pulverisette 6, n.d.)  
                                 
Figure 3-1: Milling mechanism if the planetary ball mill (Operating Instructions 
Planetary Mono Mill pulverisette 6, n.d.)  
3.2.3 Drying and sieving powder 
After milling, the powders were dried in the Ecotherm economy labotec oven at 70°C 
for 24 hours. Once the powders were completely dry, the cake formed during drying 
was granulated using a porcelain mortar and pestle prior to sieving. The powders were 
then passed through a 106 µm Retsch® stainless steel sieve using a Retsch® AS-200 
control “G” sieve shaker. This stage was essential as it allows for better green 
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compacts and enables the powder to flow appropriately during the sintering process as 
the large agglomerates have been removed. 
 
3.2.4 Mixing and Compaction of powders 
To ensure that the NH4(HCO3) foaming agent was evenly distributed into the glass 
powders, a dry mixing route was implemented. The equipment used for this was the 
Turbula T2F mixer  Willy A, Bachofen, AG. The NH4(HCO3) foaming agent and 
glass powder mixtures were prepared by mixing 2 grams which were rotated in the 
Turbula unit at a speed of 96 rpm for 30 minutes where 12 alumina milling balls  (2 
mm) were used to aid in the homogenization . The NH4(HCO3) foaming agent was 
added at  a content  of  60 vol. % and 70 vol. %. 
A hydraulic press is a device used to crush or press/compact samples in a piston-
cylinder arrangement by applying a load. In this study the powders were pressed using 
a hydraulic press (Tinius Olsen, DBBSTOL-50kN, AP32092) at a pressure of 
19.63MPa to produce pellets of 18.01mm diameter and 4 mm thick using a 
displacement range of 5 mm. 
3.3 Sintering  
3.3.1 Sintering with and without NH4 (HCO3) 
In order to determine the sintering behaviour and produce porous bioactive glass 
scaffolds, the samples were sintered with and without NH4 (HCO3) foaming agent, 
respectively. The samples prepared without NH4 (HCO3) were sintered using a heating 
rate of 10ºC/min and sintering temperatures ranging between 480ºC and 600ºC and at 
a holding time of 2 hours. The samples with NH4(HCO3) were sintered for 1 hour at 
540ºC for S53B50 and 500ºC for P40B10 and Sr after burning off the NH4(HCO3) 
foaming agent at 67ºC for 2 hours. All the samples were sintered in a Muffle furnace 
in air (Elite Thermal system BRF 18/5E-2416+2116). Cooling was achieved by 
switching off the furnace immediately after the sintering time. 
3.4 In vitro bioactivity 
To assess the in vitro bioactivity of the scaffolds, they were immersed in simulated 
body fluid (SBF) solution at 37°C as proposed by Kokubo et al., (1990). The SBF 
solution mimics the ionic composition of the blood plasma and the ion concentrations 
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of the solutions are summarized in Table 3.4. The simulated body fluid was prepared 
using 7.996g NaCl, 350 mg NaHCO3, 224 mg KCl, 228 mg K2HPO4·3H2O, 305 
MgCl2·6H2O, 40 ml 1M HCl acid, 368 mg CaCl2·2H2O, 71 mg Na2SO4 and 6.057 g 
tris (hydroxymethyl) amino methane, (CH2OH)3CNH2, (Tris) per litre SBF using 
deionized water. The pH was adjusted to 7.40 using 1 N hydrochloric acid with the 
aid of a pH meter. 
Table 3-4: Comparison of the ion concentration of SBF K9 with those of blood 
plasma (Kokubo et al., 1990) 
                                                    Concentration mM 
 SBF K9 Blood Plasma 
Na+ 142.0 142.0 
K+ 5.0 5.0 
Mg2+ 1.5 1.5 
Ca2+ 2.5 2.5 
Cl- 147.8 103.0 
(HCO3)
- 4.2 27.0 
(HPO4)
2- 1.0 1.0 
SO4
2- 0.5 0.5 
 
The mass of sample to volume of SBF ratio (1 m1/40mg) was kept constant for all the 
experiments. About 19-25 ml SBF was measured into 50 ml PP conical tubes and 
900-1070 mg of scaffolds were dispersed in the solution for 24, 48, 72 and 168 hours 
at 37°C in an incubating shaker (HT Infors Multitron) at an agitation speed of 100 
rpm. The experiments were conducted in duplicate. At the end of each time period, 
the change in the solution pH was measured and 5 ml were removed from the solution 
which were then diluted with deionised water. About15 ml was measured into a 15 ml 
PP conical tube and stored at 4°C for inductively coupled Plasma-Optical emission 
spectroscopy analysis.  After testing, the scaffolds were removed from the solution, 
rinsed with ethanol to stop any further reaction, dried at 37°C and the weight loss was 
measured. 
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3.5 Characterization techniques 
3.5.1 Particle size measurements 
Particle size analysis was carried out on the powders after milling. This was done to 
establish the particles sizes of the powders that were required for sintering. A 
Mastersizer 2000 (Malvern Instruments, Germany) was used to measure the particle 
size distribution of the powders. This equipment makes use of light scattering 
patterns, which are produced by passing particles through a focused laser beam. Small 
particles scatter light at large angles whereas the large particles scatter light at small 
angles. The patterns that are produced are then analysed using the Fraunhofer model 
in order to calculate the size of the particles producing the relative scattering patterns 
(Malvern: Mastersizer 2000- Integrated systems for particle sizing, 2005). 
3.5.2 Thermal Properties 
The thermal properties of the glasses were determined using differential thermal 
analyses (SDTA, Netzch F1 JUPITERe) at a heating rate of 10°C/min for particle size 
of 125-250 µm. The measurements were performed on 30 mg samples in platinum 
pans in N2 atmosphere. The glass transition temperature Tg was taken at the inflection 
point of the first endotherm, obtained by taking the first derivative of the DTA curve. 
The onset of crystallization Tc and the crystallization temperature Tp were found at the 
onset and maximum of the exothermic peak; respectively. 
3.5.3 Density measurements 
Due to the different structures of the samples prepared with and without NH4 (HCO3) 
two separate methods were used to determine the density of the samples, respectively. 
The density of the samples sintered with NH4 (HCO3) was determined using the 
geometric density and not Archimedes Principle due to the fact the some gas bubbles; 
voids and pores cannot be accessed by water. Whereas the density of the samples 
prepared with NH4 (HCO3) was determined using Archimedes Principle. 
3.5.3.1 Density of samples sintered with NH4 (HCO3) 
The density of the samples was determined using Archimedes principle. Firstly, the 
samples were immersed in distilled water (in a beaker) and then boiled for 3 hours, 
using a hot plate, in order to displace air from the pores in the sample. The thickness 
of the sintered samples was about 4 mm, therefore it was decided that 3 hours of 
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boiling is enough. After boiling the samples were cooled down to ambient 
temperature. 
The density of the material was calculated by first determining the mass of the water 
impregnated sample, i.e. suspended in water mass (ms). The sample is then removed 
from the water and dried lightly on the surface using a paper towel to remove excess 
water from the surface, and the water saturated mass (mw) is then determined. Finally, 
the dry mass (md) of the sample was measured after the sample had been dried in an 
oven for 24hours, and then cooled to ambient temperature. For accuracy each mass 
was determined five times in order to calculate a mean value which was then used to 
determine the density (ρs) and the porosity (Po) of the samples. The equation used to 
determine the density of the sample is given in equation 3.3 and the porosity in 
equation 3.4 
                     
                                        ρs = 
𝑚𝑑𝜌𝑤𝑎𝑡𝑒𝑟
𝑚𝑤−𝑚𝑠
                                                                  3.3      
                                     Po = (
𝑚𝑤− 𝑚𝑑
𝑚𝑤− 𝑚𝑠
)  𝑥 100                                        3.4 
 
3.5.3.2 Density of samples sintered without NH4 (HCO3) 
To calculate the density of the porous scaffolds, a micrometre screw gauge was used. 
In principle, the samples were placed between the end of the screw and the stud. The 
measurements were taken by adding the readings on the pitch scale and the circular 
scale. The additional 0.5 mm from the subdivision was only added when there was an 
extra line below the datum line.  
Density ρ of any substance is defined as the mass m of a unit volume of that substance 
given below: 
                                         ρ = 
𝑚
𝑉
                                      3.1                                                                   
The volume of the samples was calculated using the equation below: 
                                        V = пr2h                                           3.2 
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Where; 
r = radius obtained from the measured diameter (
𝐷
2
) of the samples 
h = measured thickness of the samples 
The mass of the samples was weighed using a balance scale 
 
3.5.4 Cutting the sintered samples  
After the densities of the samples had been determined, they were cut in half in order 
to examine their cross sections. This was done using a Struers Secotom-10 precision 
cut-off machine and a Struers diamond cut off wheel with a 12 cm diameter. The 
speed used for the cutting wheel was 3500 rpm and the sample was fed at a rate of 
0,025 mm/s. 
3.5.5 XRD analysis of powder and sintered samples 
A Bruker D2 Phaser XRD analysis instrument was used to examine the presence of 
any crystalline phases formed during the powder preparation stage as well as after 
sintering and immersion in simulated body fluid (SBF). The D2 Phaser uses Co kα 
radiation produced at 30kV and 10mA. Measurements were taken under the following 
conditions: 2θ value ranging from 10° - 90° 2θ with a step sizes of 0.02° (2θ). After 
the completion of the XRD scans, the phases present were then identified by using the 
DIFFRAC.EVA 4.0 software. 
3.5.6 SEM analysis of powder and sintered samples 
The morphology of the starting powders was investigated using a FEI Quanta 400 
FEG SEM. A small amount of the powder was carefully placed onto a graphite tape 
which was attached to a stub. To improve the conductivity of the powders and that of 
the sintered samples, they were further coated with gold and palladium. Images were 
taken at various magnifications in order to confirm the chemical composition of the 
powder. 
The sintered samples were not mounted nor polished to prevent the polyfast from 
clogging the pores on the cut surface. The samples made with 60 and 70 vol. % NH4 
(HCO3) foaming agent addition were both analysed using SEM to examine the 
homogeneity of the pore distribution in the samples as well as to confirm if a good 
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interconnection between pores was achieved. The samples sintered without any 
additive were also analysed to observe the influence of the sintering temperature on 
the crystallization. 
3.6.7 ICP analysis 
Inductively Coupled Plasma analysis was performed on immersion liquid diluted 10X 
except for the Sr scaffolds which were diluted 100X, due to the large amount of P 
present in them. Na was not quantified due to the high Na content in SBF leading to 
high inaccuracy. The emission lines used were 253.56 nm for P; 393,366 nm for Ca; 
421.552 nm for Sr; 249.772 nm for B; and 251.611nm for Si. 
 
3.5.8 Analysis of the porous scaffolds 
The structural properties of the porous scaffolds were conducted using both Mercury 
Porosimetry and X-ray micro computed tomography. These techniques are used to 
determine the porosity, pore size and pore size distribution of porous materials 
3.5.8.1 Mercury Porosimetry Intrusion 
Mercury Porosimetry intrusion is a technique used to measure pore size, total porosity 
as well as pore size distribution. The scaffolds are loaded into a penetrometer, which 
consist of a sample cup connected to a metal-clad, precision-bore, and glass capillary 
stem. The penetrometer’s cup and capillary stem are then infused with mercury. As 
pressure on the filled penetrometer increases mercury intrudes into the scaffold pores, 
beginning with pores of large diameter. The relation between the pressure (P) and the 
radius of the pores (r) that can be filled is given by Washburn’s equation (Maspero et 
al., 2001) 
                                     P = 
2𝜎 𝑐𝑜𝑠 𝜃
𝑟
                                                      3.5 
Where; 
σ = surface tension mercury 
θ = contact angle 
The open porosity of (п) is given by 
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                                     п= 
𝑉𝑖𝑛𝑡𝑟𝑢𝑠𝑖𝑜𝑛
𝑉𝑠𝑐𝑎𝑓𝑓𝑜𝑙𝑑
                                                     3.6 
Where;  
п = open porosity 
Vintrusion = total intrusion volume of mercury 
Vscaffold = volume of the scaffold 
In this study, the pore size distribution measurement was conducted using a (AutoPore 
IV 9500 V1.09, serial 833). The applied mercury pressure was 0.52 psi at an 
equilibration time of 10 seconds using an evacuation pressure and time of 50 µmHg 
and 30 minutes, respectively. 
 
3.5.8.2 X-ray micro computed tomography 
Micro computed tomography or microCT is a non-destructive technique used to 
examine internal structure of objects by creating a three-dimensional (3D) image 
using x-ray radiation. MicroCT equipment is composed of the following principle 
components: x-ray tube, radiation filters and collimator (which focuses the beam 
geometry to either a fan or cone-beam projection), specimen stand and a phosphor-
detector/charge coupled device camera (Figure 3.2).  
                                 
Figure 3-2: Principle components of a MicroCT scanner (Micro-Computed 
Tomography, 2016). 
In principle, a micro-focus x-ray tube produces radiation which is collimated and 
illuminates the object being imaged. The radiation is attenuated by the object which is 
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then detected by a charge-coupled device (CCD) camera with a phosphor layer to 
convert x-ray to visible light. A three-dimensional (3D) image of the object is then 
created by scanning at different angles as the object rotates and by reconstructing the 
two-dimensional (2D) projections into a three-dimensional image (Micro-Computed 
Tomography, 2016). 
  
In this study, the porosity analysis was conducted using micro-computational 
tomography (µCT). MicroXCT-400 (Carl Zeiss X-ray Microscopy, Inc., Pleasanton, 
USA) was used with tube voltage 140kV and current 71µA. Pixel size was 5.6 µm. 
Porosity analysis was done with Fiji using BoneJ plugin. µCT visualizations were 
done with Avizo 9.1 (FEI Visualization Sciences Group). 
3.6 Mechanical properties 
The compressive strength of the scaffolds (17 mm in diameter x 4 mm) as prepared 
and  after immersion in the SBF for the selected durations, was measured using an 
Instron testing machine (Model 1175-K5942; Instron , Advanced laboratory solutions, 
SA) at a crosshead speed of 0.5 mm/min. For the scaffolds immersed in SBF, the 
compressive strength was measured after drying the scaffolds. Two samples were 
measured for each duration, and the mean strength and standard deviation were 
determined. Ten samples were used for the as prepared scaffolds. 
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CHAPTER 4: EXPERIMENTAL RESULTS 
This chapter presents the results obtained from the synthesis of the borosilicate; 
borophosphate and phosphate bioactive glass; milling of the powders; mixing of the 
powders with NH4(HCO3); sintering of the powder; in vitro properties of the 
scaffolds in SBF; characterization of the as-sintered samples using XRD; ICP and 
SEM/EDS  as well as the density and compressive strength.  
4.1 Preparation of glass powders 
The glass powder of the glasses under investigation was milled in a planetary ball mill 
as described in section 3.2.2. This produced the following particle size distributions 
with d10, d50 and d90 values as presented in Table 4.1 and 4.2 for the glasses prepared 
with and without NH4 (HCO3), respectively. From the analyses it was observed that 
all glasses had a d50 less than 53 µm. 
Table 4-1: Results obtained from the particle size analysis after milling for 
samples sintered without NH4 (HCO3) 
Powder d10 (µm) d50 (µm) d90 (µm) 
S53B50 4.770 20.539 61.499 
P40B10 4.928 18.369 47.636 
Sr 6.460 26.365 78.221 
 
Table 4-2: Results obtained from the particle size analysis after milling for 
samples sintered with NH4 (HCO3) 
 
 
 
 
 
 
Figure 4-1 and 4-2 shows the XRD analysis of the glass powders after milling. The 
diffraction pattern showed the commonly observed hollow broad band; which is a 
Powder d10 (µm) d50 (µm) d90 (µm) 
S53B50 7.788 39.899 102.310 
P40B10 9.131 32.769 83.304 
Sr 11.982 46.258 102.413 
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typical characteristic of any amorphous material and free of any significant crystalline 
phases. 
                  
 
Figure 4-1: X-ray diffraction patterns of S53B50, P40B10 and Sr bioactive 
glasses after milling presented in Table 4-1 
 
 
Figure 4-2: X-ray diffraction patterns of S53B50, P40B10 and Sr bioactive 
glasses after milling presented in Table 4-2 
It was also observed that the amorphous peak shifted to lower 2θ values with 
increasing Strontium content as shown by the patterns of P40B10 and Sr. This shift 
may be attributed to the fact that Strontium has a higher atomic number than Calcium 
and thus scatters X-rays more effectively. 
 
SEM analysis was performed on each of the powders in order to show the 
morphology of the particles. Figure 4-3 reveals that the bioactive glass powders were 
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composed of particles exhibiting irregular shapes and a wide size distribution, with 
small particles tending to attach themselves to the surfaces of the larger ones. 
 
               
Figure 4-3: SEM images of (a) S53B50 (b) P40B10 and (c) Sr bioactive glass 
powder showing the particle size and shape prepared without NH4 (HCO3). 
                                          
     
Figure 4-4: SEM images of (a) S53B50 (b) P40B10 and (c) Sr bioactive glass 
powder showing the particle size and shape prepared with NH4 (HCO3). 
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A similar trend was observed for the bioactive glass powders prepared with NH4 
(HCO3); the glasses were amorphous and had no significant crystalline phases after 
milling and the glass particles also exhibited irregular shapes with a wide size 
distribution (see Figure 4.4). It is noteworthy to mention that the large particle size 
obtained for these glasses was due to the small force that was used during crushing 
compared to the force applied during crushing of the glasses that were prepared 
without NH4 (HCO3). This increase in particle size was crucial in that, fine particles 
were reported to enhance crystallization of bioactive glass powders (Massera et al., 
2012). 
 
4.2 Thermal properties of the glasses 
The thermal properties of the glasses, such as the glass transition temperature Tg and 
the onset of crystallization Tx were measured using a differential thermal analysis 
DTA. Figure 4-5 shows the DTA traces of the glasses S53B50, P40B10 and Sr 
respectively, recorded at a heating rate of 10ºC/min on powder samples of 125-250 
µm particle size.  
 
Figure 4-5: DTA thermographs of the glasses of investigation 
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The DTA traces of the powders of S53B50; P40B10 and Sr exhibit an endothermic 
effect at the glass transition temperature Tg (around 510°C; 509°C and 436°C; 
respectively); corresponding to the inflection point of the endotherm; followed by the 
onset temperature of crystallization Tx (672°C; 633°C and 540°C; respectively) 
corresponding to the inflection point of the endothermic and exothermic peak. In this 
study, the crystallization temperature (Tp) which is at the maximum of the exothermic 
peak was not measured. Table 4.3 summarizes the thermal properties of the glasses. 
 
Table 4-3: Glass transition temperature (Tg), onset of crystallization temperature 
(Tx) and working range (ΔT) of S53B50, P40B10 and Sr bioactive glasses; as 
determined by differential thermal analysis (DTA) 
 
4.3 Sintering of glass powder 
4.3.1 Samples sintered without NH4 (HCO3) 
The glass samples were sintered without the foaming agent in order to determine the 
sintering behavior of the glasses at the same time determine the optimum sintering 
conditions that would be used to fabricate the porous glass scaffolds. The obtained 
densities of the sintered bioactive glasses are shown in Table 4.4. The density was 
found to increase up to certain temperature followed by a decrease upon further 
increase in temperature to 600°C. This indicates that densification is inhibited at high 
sintering temperatures. 
 
 
 
Characteristic temperature (°C) S53B50 P40B10 Sr 
Glass transition temperature (Tg ±  2°C) 510 509 436 
Onset of crystallization temperature (Tx ± 2°C) 672 633 540 
Crystallization temperature (Tp ± 2°C) 725 672/704 527 
Working range (∆T=Tx – Tg ±  4°C) 162 124 104 
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Table 4-4: Composition, Temperature, Time, Density, Open porosity and 
Relative density 
Composition  Temperature 
(°C),  Time 
(Hr) 
Density  
(g/cm3) 
Open 
porosity 
(%) 
Relative 
Den (%) 
S53B50_1 520, 2 2.22±0.01 15±0.62 85 
S53B50_2 540, 2 2.31±0.01 11±0.44 89 
S53B50_3 560, 2 2.44±0.01 7±0.20 93 
S53B50 _4 580, 2 2.30±0.01 12±0.43 88 
S53B50_5 600, 2 2.30±0.01 12±0.15 88 
     
P40B10_1 520,2 2.12±0.01 28±0.45 72 
P40B10_2 540,2 2.27±0.01 23±0.27 77 
P40B10_3 560,2 2.03±0.01 31±0.52 69 
P40B10_4 580,2 2.08±0.01 29±0.34 71 
B40B10_6 600,2 2.06±0.01 30±0.00 70 
     
Sr_1 480.2 2.37±0.01 16±0.35 84 
Sr_2 520.2 2.49±0.01 12±0.24 88 
Sr_3 540,2 2.54±0.01 10±0.12 90 
Sr_4 560,2 2.60±0.01 8±0.33 92 
Sr_5 580,2 2.46±0.01 13±0.68 87 
Sr_6 600,2 2.39±0.01 15±0.19 85 
 
XRD analysis was performed on all sintered samples. Figure 4-6-4-8 shows the XRD 
patterns of the bioactive glasses for each sintering temperature for S53B50, P40B10 
and Sr, respectively. From the XRD data, it was observed that glass S53B50 and 
P40B10 had a similar behavior in maintaining an amorphous structure at the sintering 
temperature of 520 °C. On the other hand, glass Sr displayed crystallization at the 
same temperature. However as the sintering temperature was increased in all the 
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glasses, the samples began to crystallize as evidenced by the presence of sharp 
diffraction peaks with pronounced crystallization at 600°C.  
 
                       
 Ca2(SiO4)          
Figure 4-6: XRD pattern for glass S53B50 as a function of temperature 
                    
 
Figure 4-7: XRD patterns for glass P40B10 as a function of temperature 
o CaSiO3  Na2.2Ca1.9Si3O9  Si 
o Sr(PO3)2  B(PO4) 
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 Na4(P2O7)          
Figure 4-8: XRD patterns for glass Sr as a function of temperature  
 
The samples were further characterized using SEM in order to examine the 
microstructure of the samples after sintering. SEM investigations of the sintered 
bodies’ cross sections in Figure 4-9-4-11 reveal dense microstructures which correlate 
with the densification results in Table 4.4. The presence of micropores is also evident 
which could have contributed to the reduction in the density of the samples. These 
micropores might be residual porosity as a result of the incomplete sintering process. 
Furthermore; cracks were also observed on the microstructure of glass P40B10 as 
evident in Figure.4-10. This may be due to the stress exerted on the samples during 
cutting. In addition the presence of craters were also observed on the surface of glass 
Sr presented in Figure 4-11. It is possible that these craters might have been caused by 
the chirped section of the cutting blade resulting in the pull out of some materials as 
evidenced. In order to further examine the crystals formed during sintering, SEM 
micrographs were taken at high magnification as shown in Figure 4.12  
 
o Sr(PO3)2  Sr2(PO2)7 
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Figure 4-9: SEM micrographs of the cross section of glass S53B50 samples 
sintered at (a) 580°C and (b) 600°C 
          
 
Figure 4-10: SEM micrographs of the cross section of glass P40B10 sintered at 
(a) 580°C and (b) 600°C 
               
Figure 4-11: SEM micrographs of the cross section of glass Sr samples sintered 
at (a) 580°C and (b) 600°C 
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Figure 4-12: SEM micrographs of the cross section of glass samples sintered at 
600°C for glass (a) P40B10 (b) S53B50 and (c) Sr 
4.3.2 Samples sintered with NH4 (HCO3) 
One of the objectives of this project is the fabrication of porous scaffolds which will 
be achieved by sintering the glass powders with NH4 (HCO3) foaming agent with the 
sole aim of increasing the porosity of the scaffolds using the optimum conditions 
obtained from sintering the samples without NH4 (HCO3).                                      
The compacted pellets were sintered in the muffle furnace using a heating rate of 
10°C/min at temperatures of 500°C for glass Sr and 540°C for glass S53B50 and 
P40B10 with a holding time of 1 hour at the sintering temperature. The use of 
NH4(HCO3) is motivated by the high density of the samples sintered without 
porogens. The NH4(HCO3) was burned of at 67°C for 2 hours , prior to the sintering 
temperature. The obtained scaffolds were characterized in terms of density and the 
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results are shown in Table 4.5. The density was found to decrease with increasing 
NH4(HCO3) content, hence, the high porosity in the samples. 
Table 4-5: Composition, Density and Open porosity of sintered scaffolds 
Composition  Temperature 
(°C),  Time 
(Hr) 
Density  
(g/cm3) 
Open 
porosity 
(%) 
Relative 
Den (%) 
S53B50 – 60 vol.% NH
4 
(HCO
3
) 
540, 1 1,07±0.01 59±0.47 41 
S53B50 – 70 vol.% NH
4 
(HCO
3
) 
540, 1 0,86±0.01 67±0.60 33 
P40B10 – 60 vol.% NH
4 
(HCO
3
) 
540, 1 1,19±0.01 59±0.45 41 
P40B10 – 70 vol.% NH
4 
(HCO
3
) 
540, 1 0,95±0.01 68±0.48 32 
Sr – 60 vol.% NH
4 
(HCO
3
) 500, 1 1,02±0.01 64±0.34 36 
Sr – 70 vol.% NH
4 
(HCO
3
) 500, 1 0,79±0.01 72±0.00 28 
 
The XRD patterns for glass S53B50; P40B10 and Sr are shown in Figure 4.13. The 
results confirm that the two glasses had a broad shallow peak which indicates the 
glasses retained the amorphous state during sintering, while glass Sr still showed a 
glass-crystalline transition at 500°C. However, it is worth mentioning that the 
intensity of the diffraction pattern was more pronounced when the glass was sintered 
without NH4 (HCO3) foaming agent.  
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Figure 4-13: XRD patterns of the as prepared porous glass scaffolds for S53B50, 
P40B10 and Sr 
SEM analysis of the cross sections was performed to show the morphology of the 
porous structures. The images of the porous scaffolds of S53B50, P40B10 and Sr are 
shown in Figure 4-14.  The results reveal porous microstructures with well-connected 
open porosity and irregularly shaped pores; hence, the low density. The 
interconnection between the pores is clearly presented in the SEM micrographs. 
Homogeneity of pore distribution is also evident on the cross section of the scaffolds. 
All the glasses had a similar microstructure. 
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Figure 4-14: SEM micrographs of porous S53B50; P40B10 and Sr bioactive 
scaffolds mixed with (a),(c) and (e) 60 vol. % NH4 (HCO3) and (b), (d) and (f) 70 
vol. % NH4 (HCO3), sintered at 540°C and 500°C for 1 hour, respectively  
In addition, the pore walls were composed of dual microstructures (see Figure 4.15) 
with micro pores observed on the pore struts as well as all over the surface. This was 
probably due to the gas released during the sintering process. However, the micro 
pore were only clearly visible on glass P40B10 and Sr. The presence of micro pores is 
also another important feature of these scaffolds, as it is known that small pores 
favour and aid cell adhesion and allow the physiological fluids to enter the inner part 
of the scaffold (Brovarone et al., 2006). Whereas large pores >100 µm are required by 
the vascular tissues to circulate body fluids. 
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Figure 4-15: High magnification SEM micrographs of porous S53B50, P40B10 
and Sr bioactive glasses mixed with (a); (b) and (c) 70 vol. % NH4 (HCO3), 
respectively 
               
4.4 Analysis of the porous scaffolds 
For a scaffold to be ideal for any tissue engineering application, the most important 
architectural feature of the scaffold is the interconnection of the pores. To determine 
the porosity and the pore size distribution, Mercury Porosimetry Intrusion and µCT 
were performed on the scaffolds. Figure 4-16 - 4-18 shows the pore size distribution 
of S53B50, P40B10 and Sr glass scaffolds, respectively, obtained from mercury 
intrusion porosimetry. The vertical axis is a derivative of the volume of mercury 
intruded into the scaffold relative to the pore diameter (Lowell, 1984). The Figures 
show that the scaffolds have a wide pore distribution with interconnected pores in the 
range of 0.003 µm – 90. 84 µm. However, the pore network obtained from mercury 
intrusion porosimetry did not correlate with the SEM analysis which showed that the 
scaffolds had large and a wide distribution of interconnected pores; therefore, the 
scaffolds were further analysed using micro computed tomography to determine the 
pore size distribution. 
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Figure 4-16: Pore size distribution of S53B50 glass scaffolds at different NH4 
(HCO3) content; obtained from mercury intrusion porosimetry 
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Figure 4-17: Pore size distribution of P40B10 scaffolds at different NH4 (HCO3) 
content; obtained from mercury intrusion porosimetry 
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Figure 4-18: Pore size distribution of Sr glass scaffolds at different NH4 (HCO3) 
content; obtained from mercury intrusion porosimetry 
 
The 3-D µCT images of the structure of the optimized scaffolds at different NH4 
(HCO3) content are shown in Figure 4-19 – 4-21 for glass S53B50, P40B10 and Sr, 
respectively. From the images, it is evident that the pores generated and porosity 
increased with the NH4 (HCO3) as observed with the SEM analysis. There is also clear 
visual evidence of the high interconnectivity and porosity of the scaffolds. In addition, 
there appears to be a homogenous distribution of pores which are distributed 
uniformly all over the scaffolds. This trend was observed for all scaffolds. 
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Figure 4-19: An X-ray micro tomography (µCT) image of S53B50 glass scaffold 
mixed with (a) 60 vol. % NH4 (HCO3) (b) 70 vol. % NH4 (HCO3) 
                      
Figure 4-20: An X-ray micro tomography (µCT) image of P40B10 glass scaffold 
mixed with (a) 60 vol. % NH4 (HCO3) and (b) 70 vol. % NH4 (HCO3)  
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Figure 4-21: An X-ray micro tomography (µCT) image of Sr glass scaffold mixed 
with (a) 60 vol. % NH4 (HCO3) and (b) 70 vol. % NH4 (HCO3) 
Table 4.6 summarises the characterization data of the scaffolds obtained from the 
analysis. From the results, as expected, the average pore size and porosity increased as 
a function of NH4 (HCO3) content. µCT also confirmed the expected pore size range 
of the scaffolds in contrast to those obtained from the mercury intrusion method. The 
high discrepancy between the results collected by Mercury Intrusion Porosimetry 
(MIP) and micro-computated tomography (µCT) might be attributed to the different 
resolutions used during the operation. The MIP can measure pore diameters in the 
range of 3 nm to 200 µm (Westermarek, 2000). The pores measured are often the ones 
that reach the surface of the samples. On the other hand; µCT measure pore diameters 
in the range of 1 µm to 200 µm or more as observed in Table 4.6. This is due to the 
fact that the X-ray can penetrate through the material and measure pores on the 
surface and the internal structure of the materials. Furthermore, one should keep in 
mind that the porosimetry does not provide measure of the pores but rather, the 
interconnected size (Qin et al, 2007), (Gao, 2013) whereas µCT the general pore size 
as it cannot properly measure the interconnects. 
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Table 4-6: Composition; Average pore diameter and % Porosity of scaffolds  
Composition From Porosimetry From µCT 
Average 
pore 
diameter 
(µm) 
Median 
pore 
diameter 
(Volume) 
µm 
Porosity 
(%) 
Average 
pore 
diameter 
(µm) 
Maximum 
pore 
diameter µm 
Porosity 
(%) 
S53B50 – 
60 vol.% 
NH
4 
(HCO
3
) 
0.32 32.63 54.62 257.2±0.00 513.4±112.3 54.1 
S53B50 – 
70 vol.% 
NH
4 
(HCO
3
) 
3.34 52.83 67.63 257.5±146.2 518.5±102.6 61.8 
P40B10 – 
60 vol.% 
NH
4 
(HCO
3
) 
0.19 55.06 66.34 259.8±150.3 570.0±103.2 46.9 
P40B10 – 
70 vol.% 
NH
4 
(HCO
3
) 
47.55 53.07 62.52 262.3±149.1 509.3±106.3 60.2 
Sr – 60 
vol.% NH
4 
(HCO
3
) 
2.75 56.42 67.13 243.8±165.2 482.0±109.1 58.0 
Sr – 70 
vol.% NH
4 
(HCO
3
) 
3.09 68.60 75.64 285.5±138.0 519.0±89.3 64.7 
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4.5 In vitro properties 
4.5.1 Variation of pH 
 
The glass scaffolds were immersed in the simulated body fluid (SBF) for 24, 48, 72 
and 168 hours. Figure 4-22 - 4-24 presents the average pH values of the SBF solutions 
containing glass scaffolds of S53B50, P40B10 and Sr, respectively, as a function of 
immersion time and for varying contents of NH4 (HCO3) at 37°C. The pH value of the 
SBF before immersion is 7.4. The pH was found to increase with increasing 
immersion time for S53B50. Additionally, the pH values of the scaffolds with 70 vol. 
% NH4 (HCO3) was found to be slightly higher than that of the scaffolds with 60 vol. 
% content. The increase in pH was due to the leaching of Na+ and Ca2+ into the 
solution with simultaneous SiO2 rich layer formation leading to more basic pH.   
 
 
Figure 4-22: pH of SBF as a function of immersion time for glass S53B50 
scaffolds 
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The pH results for glass P40B10 and Sr scaffolds are shown in Figure 4-23 and 4-24, 
respectively. The pH of the SBF solutions was found to decrease with respect to 
immersion time. As observed with the glass scaffolds of S53B50 the pH value of the 
scaffolds with 70 vol. % NH4 (HCO3) was found to be slightly higher than those with 
60 vol. %. Meanwhile the pH values of the glass scaffolds of P40B10 and Sr with 70 
vol. % NH4 (HCO3) were also found to be slightly lower than those with 60 vol. %. 
This shows that high porosity is crucial for better permeability of fluids and release of 
ions. 
 
Figure 4-23: pH of SBF as a function of immersion time for glass P40B10 
scaffolds 
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Figure 4-24: pH of SBF as a function of immersion time for glass Sr scaffolds 
4.5.2 Variation of mass 
The change in mass of the scaffolds was also calculated in order to determine how 
much was lost during immersion. Upon immersion of the scaffolds into the SBF 
solution, the dissolution and conversion reactions that led to weight loss of the glasses 
were also the same reactions that controlled the pH of the solution, therefore, it is 
expected that the weight loss and pH data will show approximately the same trend. 
 The change in mass of glass S53B50, P40B10 and Sr scaffolds as a function of 
immersion time are displayed in Figure 4-25 - 4.27, respectively.  It is worth noting 
that while S53B50 continued to show a gradual increase in weight loss after the initial 
rapid increase; Sr showed a constant weight after the initial increase period and 
P40B10 showed almost no weight loss. Furthermore; the weight loss was found to be 
slightly higher at 70 vol. NH4 (HCO3) than at 60 vol. % for all three glasses. 
Accordingly the amount of weight loss is depended on the pH endured during 
immersion. It was observed that at higher pH the weight loss encountered was also 
high as seen with S53B50 at 70 vol. % than 60 vol. %  NH4(HCO3). Whereas at lower 
pH values as seen with P40B10 and Sr; a lower pH was associated with a high 
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percentage of weight loss. However; this observation was more evident to Sr than 
P40B10 with the scaffolds of prepared with 70 vol. %.  
 
Figure 4-25: Weight loss (%) as a function of immersion time for glass S53B50 
scaffolds 
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Figure 4-26: Weight loss (%) as a function of immersion time for glass P40B10 
scaffolds 
 
 
Figure 4-27: Weight loss (%) as a function of immersion time for glass Sr 
scaffolds 
0
0,05
0,1
0,15
0,2
0,25
0 20 40 60 80 100 120 140 160 180
W
ei
g
h
t 
lo
ss
 (
%
)
Immersion time (Hr)
P40B10_60 vol. % NH4(HCO3) P40B10_70 vol. % NH4(HCO3)
0
2
4
6
8
10
12
14
0 20 40 60 80 100 120 140 160 180
W
ei
g
h
t 
lo
ss
 (
%
)
Immersion time (Hr)
Sr_60 vol. % NH4(HCO3) Sr_70 vol. % NH4(HCO3)
74 
 
 
4.5.3 ICP analysis 
After immersion, the ion concentration in the immersion solution was quantified using 
inductive coupled plasma. Figure 4-28 presents the (a) [B], (b) [Ca], (c) P and (d) [Si] 
ion concentration upon immersion of the borosilicate glass. Upon immersion; the [B]; 
[Ca] and [Si] increases. The [P]; however was found to decrease with increasing 
immersion time. While; up to 24h of immersion; no significant differences in 
concentration could be measured; between the immersion solution containing the 
scaffolds with 60 or 70 vol. %; the later showed drastically increased ion 
concentration at longer immersion time.  
  
 
Figure 4-28: Ion concentration in the immersion solution of S53B50 for (a) [B] , 
(b) [Ca], (c) [P] and (d) [Si] as a function of time 
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Figure 4-29 presents the (a) [B]; (b) [Ca]; (c) [P] and (d) [Sr] ion concentration upon 
immersion of the borophosphate glass. While a general increase in [B]; [P] and [Sr] 
can be seen; the [Ca] was found to decrease. As explained in Fig 3; all variation are 
more pronounced in when scaffolds containing 70 vol. % are immersed in SBF. It is 
also interesting to point out the change in ion release of the borosilicate glass (Figure 
4-28) compared to the borophosphate glass (Figure 4-29). Indeed the scale for the ion 
being released (especially [B]) are lower upon immersion of the borophosphate 
compared to the borosilicate.         
Figure 4-30 presents the (a) [Ca]; (b) [P] and (c) [Sr] ion concentration upon 
immersion of the phosphate glass. Upon immersion for 24h; the [P] and [Sr] increases 
and then remain almost constant for longer immersion time. The [Ca]; however; 
decreases during all imersion test. As opposed to the other tested materials; here no 
significant differences could be seen between the scaffolds produced with 60 or 70 
vol. % of NH4(HCO3). 
              
Figure 4-29: Ion concentration in the immersion solution of P40B10 for (a) [B], 
(b) [Ca], (c) [P] and (d) [Sr] as a function of time 
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Figure 4-30: Ion concentration in the immersion solution of Sr for (a) [Ca], (b) 
[P] and (c) [Sr] as a function of time 
4.5.4 Phase and Microstructural analysis 
4.5.4.1 XRD analysis 
To confirm that the spherical particles formed on the glasses surfaces was indeed HA 
particles; a phase analysis was carried out using XRD on the scaffolds immersed for 
24, 48, 72 and 168 hours in SBF. Figure 4-31 - 4-32 presents the XRD patterns for 
glass S53B50 scaffolds. The as prepared glass scaffold (seen in Figure 4.12) showed 
the commonly observed shallow broad peak, which is a typical characteristic of any 
amorphous glass material. On the other hand, the XRD patterns of the immersed 
samples showed a major peak at 36° corresponding to that of HA as reported 
(Erasmus et al, 2017).This results shows that SBF dissolves the scaffolds with the 
formation of a weak crystalline phase of Ca4O(PO4)2.Normally this peak is found at 
about 32° when using Cu Kα; however in this case the use of Co Kα may have caused 
a shift in the peak position. These peaks increased in intensity as the immersion time 
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and porosity increased. However, as observed by Fu et al., (2007), the peak intensities 
were still well below those for a standard crystalline HA; this clearly indicates that the 
as-formed HA was incompletely crystallized or only weakly crystalline. 
 
 
 
 Ca4O(PO4)2    
Figure 4-31: XRD traces of S53B50-60 vol. % NH4(HCO3) immersed in SBF for 
24; 48;72 and 168 hours  
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 Ca4O(PO4)2    
Figure 4-32: XRD traces of S53B50-70 vol. % NH4 (HCO3) immersed in SBF for 
24, 48, 72 and 168 hours 
The phase analysis for glass P40B10 and Sr was only carried out on scaffolds 
immersed for 168 hours in SBF as presented in Figure 4-33 and 4-34 respectively. 
The XRD results for both compositions (60 and 70 vol. %) were chosen at 168hrs to 
assess the formation of the HA layer only. The XRD pattern of P40B10 immersed for 
168hrs remained identical to the untreated one. This shows that SBF dissolves the 
scaffolds without the formation of crystalline phase. On the other hand, a phase 
difference was observed for the Sr scaffolds before and after immersion in SBF. This 
is evident by the reduction in peak intensity, formation of new peaks as well as the 
disappearance of some peaks. 
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Figure 4-33: XRD traces of P40B10 mixed with 60 and 70 vol. % NH4 (HCO3) 
immersed in SBF for 168 hours 
 
 Sr P2O6    
Figure 4-34: XRD traces of Sr mixed with 60 and 70 vol. % NH4 (HCO3) 
immersed in SBF for 168 hours 
4.5.4.2 SEM images 
 
Figure 4-35 – 4-36 presents SEM micrographs of the scaffold surfaces of glass 
S53B50 after immersion in SBF for 24, 48, 72 and 168 hours. The images show that 
upon immersion precipitation of spherical particles occurs. These particles were also 
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found inside the pores of the scaffolds; which indicates good interconnectivity; hence; 
good permeability of the fluid. Interestingly; apart from the particles that were formed 
at the glass surface; a reactive layer also formed around the mouth of the pores. 
 
               
Figure 4-35: SEM images of the surface of S53B50-60 vol. % NH4 (HCO3) 
bioactive glass scaffolds after immersion in SBF for (a) 24, (b) 48 , (c) 72 and (d) 
168 hours 
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Figure 4-36: SEM images of the surface of S53B50-70 vol. % NH4 (HCO3) 
bioactive glass scaffolds after immersion in SBF for (a) 24, (b) 48, (c) 72 and (d) 
168 hours 
Figure 4-37 presents the SEM image and corresponding EDX analysis of one of the 
particle. From EDX analysis the Ca/P ratio is found to be 1.65. The presence of Si and 
Na come most likely from the glass underneath the particles. This is expected given 
the high penetration of X-ray. 
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Figure 4-37: EDS spot analysis of as-formed HA particles on glass S53B50-70 
vol. % NH4 (HCO3) after immersion in SBF for 24 hours 
 SEM images of the glass scaffold surface of P40B10 and Sr shown in Figure 4-38 
and 4-39, respectively. In the case of the borophosphate scaffolds (Figure 4-38); signs 
of a reactive layer formation could be seen. However the surface coverage and the 
amount of globular particles was low. The phosphate scaffolds SEM images exhibit 
the evolution of a surface texture which cannot be related with the deposition of a 
reactive layer.           
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Figure 4-38: SEM images of the surface of P40B10-60 vol. % NH4 (HCO3) 
bioactive glass scaffolds after immersion in SBF for (a) 24, (b) 48, (c) 72 and (d) 
168 hours 
                                                             
 
Figure 4-39: SEM images of the surface of Sr-60 vol. % NH4 (HCO3) bioactive 
glass scaffolds after immersion in SBF for (a) 24, (b) 48, (c) 72 and (d) 168 hours 
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Figure 4-40 presents the EDS analysis of the P40B10 surface after 168hrs immersion.  
From the calculation of the Ca + Sr/P ratio; the ratio was found to be 04.5 which 
correponds to the ratio of the original glass composition (~0.5). 
 
Figure 4-40: EDS spot analysis of the as-formed HA particles on glass P40B10-70 
vol. % NH4 (HCO3) after immersion in SBF for 168 hours  
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Figure 4-41: EDS spot analysis of the as-formed HA particles on glass Sr-60 vol. 
% NH4 (HCO3) after immersion in SBF for 24 hours 
Figure 4-41 presents the EDS analysis of the HA particles formed on the glass surface 
of Sr after immersion for 168 hours.             
4.6 Mechanical properties 
The compressive strength of the scaffolds before and after immersion in SBF as a 
function of immersion time and NH4 (HCO3) content are presented in Figures 4-42 
and 4-43. The data in Figure 4-42 show that the compressive strength decreased 
significantly after 24 hours of immersion. This instant decrease in strength is a result 
of the porous structure of the scaffold as well as the dissolution of ions from the 
samples. The compressive strength of the immersed scaffolds was found to be slightly 
lower than the as prepared scaffolds. However, slightly higher compressive strength 
after immersion was also observed. Additionally lower compressive strengths were 
obtained at high NH4 (HCO3) content. 
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Figure 4-42: Compressive strength of scaffolds as a function of immersion time 
in SBF at 60 vol. % content  
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Figure 4-43: Compressive strength of scaffolds as a function of immersion time 
in SBF at 70 vol. % content  
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CHAPTER 5: DISCUSSION 
This chapter gives a detailed explanation of the results obtained in Chapter 4. This 
includes the thermal properties of the glasses, densification and microstructural 
analysis of the sintered samples and their in vitro properties in simulated body fluid, 
mechanical properties  
5.1 Densification and Microstructure of sintered glasses 
5.1.1 Effects of particle size on crystallization 
 
The particle size of the sintered glass powders with or without NH4 (CO3) has shown 
to have a critical effect on the crystallization of the glasses. The particle size for 
samples without NH4 (HCO3) were in average 20.5 µm, 18.4 µm and 26.4 µm for 
glasses S53B50, P40B10 and Sr respectively, while the average particle size for the 
glass powders sintered with NH4 (HCO3) was 39.9 µm, 32.8 µm and 46.3 µm for 
S53B50, P40B10 and Sr respectively. When the glass particles sintered without NH4 
(HCO3) were used, the samples were fully dense as small particles have a greater 
driving force for sintering and allow better viscous flow of particles. However, small 
particles also have a large surface area. This not only increases the number of 
nucleation site, but also enhances the crystallization tendencies of the glasses by 
increasing the intensity of the exothermic peaks at low temperatures (Massera et al., 
2012). Aside from the particles size which might affect the crystallization kinetics, the 
presence of carbon, from the binder, at the particles surface may inhibit 
crystallization. This effect is mostly dominant with glass Sr, where crystallization is 
observed at temperatures as low as 480°C (Figure 4.7). Meanwhile, when the glass 
particles sintered with NH4 (HCO3) were used, the scaffold struts were fully dense and 
the particles were properly fused together despite the slightly larger particles. An 
advantage offered by the larger particles is the ability to sinter the glasses at the same 
temperature (as in the case of glass S53B50 and Sr sintered at 540°C (Figure 4.12) 
and still be able to control their crystallization. This is because large particles begin 
crystallising at higher temperatures for the reasons given above, thereby creating a 
wide sintering range. When the particle size of glass Sr was increased, it still endured 
crystallization but it was less pronounced.  
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Wu et al., (2011) observed a similar behaviour, they showed that fine particles with 
<38 µm produced structures that were intact and well sintered with good particle 
packing and stacking. Unfortunately they had a large surface area which created a 
platform for crystal nucleation as recognised in this work. Meanwhile, the particle 
with >38 µm did not allow efficient sintering at 700°C as the particles were not 
properly fused together, hence, structures were not fully dense. Figure 5.1 presents the 
crystallization temperature of different bioactive glass as a function of particle size. 
Although these glasses have different composition, the commencement of 
crystallization was found to occur at temperatures lower than their onset of the 
crystallization temperature due to the small glass particles used during sintering. 
 
 
Figure 5-1: Crystallization temperature as a function of particle size (glass 45S5 
(Fagerlund et al., 2010); glass S53P4 (Massera et al., 2012)  and glass ICIE (Wu et 
al., 2011)) 
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crystallization) were quantified and are indicated in the figures as well as in Table 4.3. 
∆T (∆T=Tx-Tg), also presented in Table 4.3, is a gauge to the glass resistance to 
crystallization Fagerlund et al., (2012a) and is often referred to as the hot working 
domain. According to Brauer, (2015), crystallization of bioactive glasses can be 
controlled by increasing the working range which is the temperature difference 
between crystallization and the glass transition. This stability range, ∆T, is the 
temperature range in which glass viscosity allows for sintering, fiber drawing, or other 
processing. A large temperature gap between glass transition and onset of 
crystallization suggests that viscous flow is more likely to occur prior to the 
crystallization. A small temperature gap between glass transition and onset of 
crystallization suggests a nucleation close to the glass transition temperature and 
therefore more risk of nucleation and growth of crystals, prior or during sintering. 
This phenomenon is depicted in Figure 5.2. 
 
                           
Figure 5-2: Effect of glass stability range (ΔT) on viscous flow sintering 
 
As  the primary objective is to sinter the glass particles by viscous flow sintering 
without any measurable crystallization, all sintering temperature should be chosen 
within the hot forming domain, i.e. between 510°C and 672°C, 509°C and 633°C, 
430°C and 540°C for glasses S53B50, P40B10 and Sr, respectively. It is noteworthy 
that all glasses are expected to have a surface initiated crystallization as demonstrated 
for the Sr glass Massera et al., (2015c)  and for typical silicate bioactive glasses 
(Massera et al., 2012) , (Massera and Hupa, 2014). It is therefore expected that with 
small particle size the risk of crystallization upon increasing temperature increases 
91 
 
due to an increase in the number of  nucleation sites with increasing the surface area 
to volume ratio (Filho et al., 1996) ,(Massera et al., 2012) ,(Marrota et al., 1981) 
,(Ray and Day, 1997). Glass S53B50 and P40B10 have a wider processing window 
than glass Sr; therefore, the Sr glass is the most likely to endure crystallization during 
the sintering process.  
 
                    
Figure 5-3: Relative density of S53B50, P40B10 and Sr bioactive glasses as a 
function of temperature sintered without NH4 (HCO3) 
 
The density of the sintered samples was determined by the Archimedes principle. 
From the density results presented in Figure 5-3, it can be seen that the relative 
density increased with increasing temperature. However, a decrease was observed 
when the temperature was increased beyond 560°C for glasses S53B50, Sr and 540°C 
for glass P40B10. The decrease in density may be attributed by the inhibition of the 
viscous flow of the particles caused by surface nucleation and/or crystallization; 
hence, particles may not fuse together properly during sintering resulting in poor 
densification of the material.  
Glass P40B10 samples showed the same trend, but with slightly lower densification 
than S53B50 and Sr. This may be due to the fact that glass P40B10 has high 
activation energy for viscous flow. The maximum densification (TD %) achieved for 
glasses S53B50, P40B10 and Sr were 93%, 72% and 92% respectively. 
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From the XRD results of the samples shown in Figure 4.5 – 4.7, Figure 4.5 and 4.6 
showed the onset of crystallization at temperatures between 520°C and 540°C while 
Figure 4.7 showed crystallization transition at 480ºC. With an increase in temperature 
the diffraction peaks sharpen and increase in intensity, as expected, due to an 
increasing crystallinity of the glass. This means that glass S53B50 and P40B10 can be 
sintered up to 540ºC without undergoing adverse crystallization in contrast to glass Sr, 
which will undergo crystallization at any sintering temperature. As expected, the 
crystallization occurs at lower temperature than Tc due to the small size of the glass 
particles sintered compared to the one analyzed by DTA. The XRD patterns also show 
the transitional behavior which led to the crystallization of the individual glasses. 
Furthermore it can also be seen that the density of the samples decreases as the 
intensity of the peaks increases with temperature. This evidently shows how 
crystallization affects the densification of amorphous materials.  
 
SEM images of the cross section of the sintered samples revealed a dense 
microstructure which explains the high theoretical densities obtained between 
sintering temperatures of 480°C – 560°C as shown in Figure 4.8-4.10. However at 
580°C - 600°C the presence of micropores is also evident, which contribute to the 
reduction in theoretical density as observed. These micropores might be residual 
porosity as a result of the incomplete sintering process. Figure 4.11 shows the SEM 
micrographs, recorded with backscattered electrons, of the samples sintered at 600°C 
for glass (a) P40B10 (b) S53B50; and (c) Sr at high magnification. There is strong 
evidence of crystals forming in the P40B10 glass; whereas the darker areas 
correspond to the crystals and the brighter areas to the remaining glass. This strongly 
correlates with the XRD patterns in Figure 4.6. SEM investigation of glass S53B50 
showed almost no or minor presence of crystals. This is in agreement with the XRD 
pattern (Figure 4.5) exhibiting low number of diffraction peaks with low intensity 
indicating reminiscence of a mainly amorphous matrix. The XRD patterns of glass Sr 
(Figure 4.7) show adverse crystallization and this is clearly aided by the SEM 
micrographs of the glasses which reveal high volume of crystals present on the cross 
section of the samples. Similar results have been reported by Massera et al., (2015c) 
where rapid surface crystallization led to fully crystallized particles at such 
temperatures. In contrast to the crystallization mechanism of glass S53B50; crystals of 
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glass P40B10 appeared to be irregularly shaped and clustered together while crystals 
of glass Sr exhibit a thatch like shape covering the surface of the sintered body. 
As observed by the high densification results obtained in Figure 5.3, the porosity 
achieved during sintering was too low to meet one of the requirements of an ideal 
scaffold, which is high porosity; therefore it was necessary to add porogens in order to 
increase the porosity. In this work, the required porosity was obtained by mixing NH4 
(HCO3) with the glass powder. The low densification results obtained in Table 4.5 
indicates that high porosity was obtained by incorporating NH4 (HCO3) as the pore 
forming agent. This was achieved by burning out the pore forming agent NH4 (HCO3 
before sintering, thereby creating the pores as observed in Figure 5.4. As the sintering 
temperature was increased, the glass particles fused together and densified around the 
pores. This action is illustrated in Figure 5.4. In addition the formation of such high 
porosity may also be attributed by the high volume expansion (more than 1000 times) 
ratio during decomposition of NH4 (HCO3) (Locs et al., 2013). 
      
Figure 5-4: Schematic diagram on the fabrication of highly porous scaffolds 
during sintering 
A similar trend was observed by Locs et al., (2013), whereby the open and total 
porosity were found to increase from 25 to 69% and from 32 to 73% when NH4 
(HCO3) content was varied from 0 to 2.75 wt. %. The investigated glass compositions 
reached an open porosity of more than 60% at the addition of 70 vol. % (0.56 wt. %) 
NH4 (HCO3), with glass Sr obtaining the highest open porosity of 72%. Table 5.1 
presents the sample compositions as prepared by Locs et al., (2013) and the glass 
samples investigated in this work. From the table, the low content of NH4HCO3 added 
as a function of wt. %  to the HAp powder resulted in a low open porosity in contrast 
to the high contents of NH4HCO3 that was incorporated into the bioactive glass 
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powders; hence, the high porosity despite the glasses having a lower wt. %. The 
addition of the small amount of NH4HCO3 used by Locs et al., (2013) despite having 
a high wt.% could be due to the fact that they used a fixed mass for HAp; whereas in 
this work, the overall mass (of 2 grams) was composed of both the glass powders and 
NH4HCO3 foaming agent with the mass of the foaming agent determined by the 
respective wt. %. 
Table 5-1: List of sample compositions 
HAp 
Sample 
HAp 
,g 
NH4HCO3, 
g 
NH4HCO3, 
wt. % 
Glass 
samples 
Powder, 
g 
NH4HCO3,
g 
NH4HCO3, 
wt. % 
S4 2.6 0.00 0.00 0 2.00 0.00 0.00 
S5 2.6 0.05 0.90 B50-60 1.05 0.95 0.48 
S6 2.6 0.06 1.10 B50-70 0.83 1.17 0.59 
S7 2.6 0.07 1.30 B10-60 1.11 0.89 0.45 
S8 2.6 0.08 1.40 B10-70 0.89 1.11 0.56 
S9 2.6 0.10 1.80 Sr-60 1.09 0.91 0.46 
S10 2.6 0.15 2.70 Sr-70 0.87 1.13 0.57 
 
5.2 In vitro properties of the scaffolds 
5.2.1 Variation of pH  
The pH of the SBF was assessed as a function of time. As mentioned earlier; the 
dissolution and conversion reactions that led to weight loss of the scaffolds are 
expected to be the same reactions that control the pH of the SBF solution. Evidently, 
the increase in pH of the SBF with immersion time of the scaffolds showed similar 
trend with weight loss results. The increase in pH of S53B50 SBF solution (Figure 
4.21) might have resulted from the dissolution of glass ions such as Si4-, Na+, Ca2+ 
ions which increased the pH of solution.  This increase in pH is typical for silicate 
bioactive glasses (Zhang et al., 2008) and is known to aid apatite formation (Aina et 
al., 2009), (Brauer et al., 2010), (Fredholm et al., 2012). The dissolution mechanism 
that leads to the increase in pH is shown in Figure 5.5. 
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Figure 5-5: Initial ion dissolution mechanism of conversion of glass S53B50 to 
HA 
The decrease in pH of P40B10 and Sr solutions (Figure 4.22 and 4.23, respectively) 
may be related to the change in P content in the solution which will reduce the 
alkalinity/basicity caused by the dissolution of Na+, Ca2+ and Sr2+ ions as shown in 
Figure 5.6. In addition, glass P40B10 and Sr contain high contents of P2O5, and the 
dissolution of phosphate glasses being congruent often leads to larger amount P5+ ions 
being released into the solution. Therefore when the (P2O5) ions were being released 
into the solution, it may have reacted with water to form phosphoric acid (H3PO4
-) 
which consequentially dissociates producing H3O
+ and PO4
3- ions causing a decrease 
in pH due to the increase of dissociated H3O
+. Although this acidic environment is not 
desirable for the formation of apatite, it has been reported by Krajewshi and 
Ravaglioli, (2002) that a low pH is also advantageous for bioactivity as a pH of 7.2 is 
still optimal in physiological fluid for apatite formation. 
(a)         (b) 
Figure 5-6: Initial ion dissolution mechanism of conversion of glass (a) P40B10 
and (b) Sr to HA 
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5.2.2 Variation of mass 
The results of the weight loss in Figure 4.24 indicate that the addition of B2O3 in the 
borosilicate glass (S53B50) composition resulted in an increase in the conversion rate 
of the scaffolds. It is known that the addition of B2O3 brings changes in the glass 
network which disrupts the 3D Si-O network and forms [BO3
-] trihedral or chains of 
(BO3) triangles. In contrast to Si, it is difficult for B to completely form a 3D network 
due to its threefold coordination number; this effect aids the apatite formation of 
biomaterials. On the other hand, the conversion rate of P40B10 and Sr shown in 
Figure 4.25 and 4.26, respectively may be associated with the substitution of CaO 
with SrO, since SrO and CaO are both glass modifiers and have similar coordination 
numbers; they are expected to have the same effect in the glass network. However, 
despite both compositions having similar SrO content, glass Sr had the fastest 
dissolution rate and weight loss. This may be due to the addition of B2O3 into the 
P40B10 composition which stabilized the system as well as the partial substitution of 
SrO for CaO, whereas for Sr, CaO was fully substituted by SrO as it has been reported 
that full substitution enhances apatite formation.   
5.2.3 ICP analysis 
As seen in Figure 4.21, the pH of the solution increased with immersion time. This 
increase in the solution’s pH can be attributed to the release of B3-, Ca2+ and Si4- ions 
in solution as supported by the concentration in Figure 4.27a, b and c. Meanwhile the 
decrease in the solution’s pH of P40B10 and Sr presented in Figure 4.22 and 4.23 
respectively was due to the increase in P content as shown Figure 4.28 and 4.29, 
respectively. This increase indicates phosphorus was released into the solution from 
the glass surface, on the other hand, a decrease in P content as observed for glass 
S53B50 indicate phosphorus was taken up by the scaffold from the solution. 
Normally it is expected that, with large content of P released into the solution, the 
amount of calcium consumed from the solution will also be high. However, in this 
work it has been observed that despite glass Sr having released a higher concentration 
of P than glass P40B10 there was no difference in the amount of Ca consumed. This 
also explains why glass P40B10 had a more stable or less pH variation than glass Sr. 
Additionally, Massera et al., (2013) reported that by increasing the SrO content of 
phosphate glasses a large consumption of Ca is expected, however contrary to this 
study, it was found that an increase in SrO content in glass Sr had no effect on the Ca 
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consumed as both P40B10 and Sr had a similar Ca concentration profile despite the 
difference in SrO content. Nonetheless, the decrease in Ca content suggested that HA 
was progressively being formed on the glass surfaces as this indicates that the Ca2+ 
ions were consumed when the glasses were. Whilst on the other hand, an increase in 
Ca content for glass S53B50 shows that the Ca2+ ions were released from the glass 
surface into the solution and this action also supports the formation of HA on the glass 
surface. The increase in Sr concentration of glass Sr with respect to SrO was also 
observed by (Fredholm et al., 2012), (Massera et al., 2013). Si was progressively 
released into the solution from the glass surface and its concentration increased with 
immersion time as observed in Figure 4.21d. Jones et al., (2006) also observed a 
similar behaviour from their 70S30C bioactive glass foams. 
5.2.4 Phase and Microstructural analysis 
5.2.4.1 XRD analysis 
The XRD patterns for glass P40B10 scaffolds (see Figure 4-33) showed a broad 
shallow peak which indicates that even after being immersed for 168hrs, they 
maintained the amorphous state. This does not necessarily mean that no HA was 
formed, but it is possible that the precipitated HA was rather amorphous and did not 
fully crystallize. Meanwhile, although the as-prepared scaffolds of glass Sr showed 
adverse crystallization during sintering, this did not prevent the scaffolds from 
reacting or forming HA. When compared to the XRD patterns of the as-prepared 
scaffolds, the immersed scaffold (shown in Figure 4-34) showed a reduction in peak 
intensity, formation of new peaks as well as the disappearance of some peaks. This 
clearly indicates that crystallization did not inhibit the reactions that led to the 
formation of HA. Additionally, strontium phosphate (SrP2O6) was found to be the 
main phase formed in glass Sr; this does not necessarily mean that strontium 
substituted HA particles were formed on the glass surface but indicates that the glass 
scaffolds were enriched with Sr and P. However, it is difficult to state if the as formed 
HA particles were crystalline or amorphous. 
 
5.2.4.2 SEM analysis 
SEM images show the formation of HA particles on the surfaces of all glasses as 
indicated by the arrows in Figure 4-31 - 4-32 for S53B50. SEM/EDX analysis were 
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also performed on the on the scaffolds with 70 vol. % and the same HA precipitation 
was observed. The images show that apatite starts to grow in a spherical morphology 
on the glass within 24 hours and completely covers the surface within the week. These 
particles were also found inside the pores of the scaffolds; which indicates good 
interconnectivity; hence; good permeability of the fluid. Similar particles which are 
typical of HA deposited by precipitation from solution were observed by (Fu et al., 
2010), (Chen et al., 2006). A typical behavior of bioactive glasses is the formation of 
a silica rich layer during the conversion reactions. This layer often forms on the 
surface of the glasses and separates the precipitated HA from the unconverted glass. 
This indicates that the apatite (HA) is easily nucleated on the silica gel when the 
starting pH of the environment increases slightly and this formation of HA clearly 
correlates with the pH variation in Figure 4.22. The presence of this layer/gel is often 
evidenced by the formation of scales on the glass surface aided with cracks endured 
during sample drying (see Figure 5-7). In addition alkaline solutions are known to aid 
apatite formation. Interestingly; apart from the HA particles that were formed on the 
glass surface; an HA layer was also formed around the mouth of the pores.  
 
Figure 5-7: SEM images of the surface of S53B50-70 vol. % NH4 (HCO3) 
bioactive glass scaffolds after immersion in SBF for 24 hours 
 
It is well known that the ideal stoichiomteric Ca/P ratio of HA is 1.67, therefore it was 
necessary to carry out EDS analysis (shown in Figure 4-37) on the as-formed HA 
99 
 
particles and determine its Ca/P ratio. The Ca/P atomic ratio was found to be 1.65 
which is close to the value (1.67) , this indicates conversion of  the S53B50 glass to 
HA. 
 
The presence of these globular particles are present in all samples, however they 
become fewer with decreasing pH as observed for P40B10 and Sr scaffolds shown in 
Figure 4-38-4-39, respectively. A typical behaviour of bioactive glasses is the 
formation of a silica rich layer during the conversion reactions. This layer often forms 
on the surface of the glasses and separates the precipitated HA from the unconverted 
glass. Due to its porous nature there is a continuous dissolution of ions through the 
SiO2-rich layer into the solution. Eventually the Ca
2+ from the glass surface and PO4
3- 
from the solution react resulting in the precipitation and growth of HA on the glass 
surface. Meanwhile the HA particles formed on glass Sr and P40B10 were a result 
from the reaction between Sr2+ and PO4
3- which allowed for precipitation of strontium 
substituted HA particles. These mechanisms are presented in Figure 5-8 which shows 
the adhesion of Ca2+, PO4
3- and Sr2+ ions to the silica gel surface forming a bone-like 
HA. 
(a)    (b)  
Figure 5-8: Final mechanism of conversion of glass (a) S53B50, (b) P40B10 and 
Sr to HA in SBF 
The EDS analysis for glass P40B10 are shown in Figure 4-39 after immersion for 168 
hours. From the Ca + Sr/ P ratio; the ratio was found to be 0.45  which is far from the 
conventional ratio of HA which has been reported to be around 1.67. This indicates 
that the as-formed HA particles did not fully crystallize to HA and this behaviour was 
also supported by the XRD results in Figure 4-32  where no HA peaks were detected. 
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Figure 4-40 showed the EDS analysis of the Sr scaffold after immersion for 24 hours. 
An observation from this analysis is the presence of Ca on the glass surface, this 
indicates that some Ca2+ has precipitated from the solution in the surface layers. It is 
note worthy that this was a CaO free glass.  
The formation of HA is presented in the form of small spherical particles in the above 
Figures. When these dissolution and precipitation reactions are allowed to continue a 
thick reaction product layer is often formed from the surface of the particle inward. In 
this case; this layer is formed around the pore (see Figure 4-36a and d). It is worth 
noting that the cracks observed on the glass surfaces are the dried silica gel which 
occurred during drying of the scaffolds after immersion. In addition the presence of 
the HA particles on the glass surface corresponds to the HA peaks observed on the 
XRD traces. EDS analysis in Figure 4-37 showed that the scaffolds had a Ca/P ratio 
of 1.65 which is close to the stoichiometric value of HA. This essentially indicates 
that the reaction almost completely converted to HA. 
It is noteworthy to mention that, although HA particles were formed on the glass 
surface of P40B10, XRD traces (in Figure 4-33) showed no HA peaks. This clearly 
confirms that the HA particles were incompletely crystalline hence the broad 
amorphous XRD pattern. Additionally, as expected, HA formed much faster on glass 
Sr scaffolds compared to P40B10 as a result of its fast dissolution rate and high 
phosphate content.  
5.3 Mechanical properties 
The mechanical properties of the glass scaffolds obtained from sintering of particles 
in different particle size with different porosities were measured. The mechanical 
strength was found to decrease for all particle size as the porosity of the scaffold 
increases. This is due to the increase in void space on the scaffold which makes the 
scaffold structurally prone to collapse even at lower mechanical stress. It is also well 
reported in literature that porous structures have relatively high porosities which 
consequently results in the materials having poor mechanical strength. 
The compressive strength of the as-prepared scaffolds (Figure 4-42) of S53B50 was 
1.29 ± 0.21 MPa. In comparison, the compressive strength of the as prepared scaffold 
of P40B10 was 1.56 ± 0.63 MPa while Sr had strength of 3.63 ± 0.69 MPa. This value 
was found to be in the range of 2 – 12 MPa which has been reported for the 
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cancellous bone (Rahaman et al., 2011). All these values were obtained at 60 vol. % 
content of NH4 (HCO3).  Figure 4-43 also shows that upon immersion in SBF, the 
compressive strength of the scaffolds decreased with increasing immersion time and 
porosity. In addition, as was expected, the compressive strength of the scaffold after 
immersion was found to be lower than that of the as-prepared although it was also 
observed that some scaffolds had high strength after immersion. Glass S53B50 had a 
moderate degradation rate and it is clearly evident that the foaming agent content had 
no significant change in the compressive strength of the scaffolds immersed from 24 
to 168 hour in SBF. Meanwhile glass P40B10 which has the slowest degradation rate 
was found to maintain its mechanical properties for a longer time. It is worth noting 
that the scaffolds of glass P40B10 did not display any monotonic decrease or increase 
and the unusual high strength was observed for these scaffolds after immersion. Once 
again this might be due to some debris from degradation which filled up the pores. 
Lastly, glass Sr showed a trend similar to glass S53B50. However its fast degradation 
and reaction time lead to a drastic decrease in compressive strength as can be seen in 
Figure 4-42 and 4-43. In addition, the high strength of glass Sr might be due to the 
crystalline phases formed in the amorphous matrix, as it has been reported by Kauer et 
al., (2014) that crystallization enhances the mechanical properties of bioactive glass. 
However, this strength comes at the expense of the glass bioactivity as observed with 
the slow conversion to HA. Furthermore it was also observed that there is no 
correlation between the sintering temperature and the mechanical properties of the 
scaffolds. Normally it is expected that at high sintering temperature a high 
compressive strength is to be obtained due to the well densified and strong struts of 
the scaffolds formed during sintering, however in this work, the compressive strength 
of S53B50 and P40B10 were found to be lower compared to Sr, despite Sr being 
sintered at a temperature 40°C lower than the sintering temperature of S53B50 and 
P40B10. This also indicates that Sr particles bond better during sintering compared to 
the particles if S53B50 and P40B10. 
 
The stress/strain curves recorded during the compression test of the scaffolds are 
shown in Figure 5-9 – 5-10 for glasses S53B50, P40B10, respectively. Figure 5-9 
showed a typical rupture of ceramic foam (Gibgson and Ashby, 1988): which in this 
case no elastic region was observed; however an initial fracture of the solid walls 
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between pores is clearly displayed by the curve which ends by failure of the scaffold 
struts normally as a result of cracking, bending or buckling. These actions provide the 
maximum compressive strength of the scaffolds. The curve is further characterized by 
the progressive failure of the pore walls until the scaffolds become powder followed 
by the densification region which signifies compression of the powder. This same 
compressive behaviour was observed by Jones et al., (2006) when they tested the 
compressive strength of their 70S30C glass foams, however their foams displayed an 
elastic region. The stress/extension curve for P40B10 scaffolds is shown in Figure 5-
10 and exhibits a similar behaviour; however the densification region is not reached 
here due to the fragmentation of the scaffolds. 
 
Figure 5-9: Typical stress/extension curve for S53B50 prepared with 70 vol. % 
NH4 (HCO3) immersed in SBF for 168 hours 
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Figure 5-10: Typical stress/extension curve for P40B10 prepared with 60 vol. % 
NH4 (HCO3) immersed in SBF for 168 hours 
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CHAPTER 6: CONCLUSIONS and FUTURE WORK 
In this thesis, the potential for the processing of scaffolds for tissue engineering was 
assessed for three glass types, i.e. borosilicate (S53B50), borophosphate (P40B10) 
and phosphate (Sr). These glasses were found, in the past, to have promising 
antimicrobial and dissolution properties towards healing of injured bones. However, 
in tissue engineering it is well accepted that a scaffold with large porosity and 
interconnected pores is required to reach optimum clinical application. 
The crystallization and sintering ability of S53B50, P40B10 and Sr was investigated 
without the addition of NH4 (HCO3) foaming agent in the temperature range of 480°C 
– 600°C. Glasses S53B50 and P40B10 were found to exhibit crystalline peaks at 
540°C while glass Sr does so at 480°C; this suggests that glass Sr is highly prone to 
crystallization due to its lower glass stability. Bioactive glass scaffolds from these 
compositions (S53B50, P40B10 and Sr) were produced by using a foaming agent 
(NH4 (HCO3)) at a content of 60 and 70 vol. % followed by sintering using a heating 
rate of 10°C/min for 1 hour at 500°C and 540°C for glass Sr and S53B50, P40B10, 
respectively. It was found that, increasing the size of the glass particles inhibited to 
some extent the glass crystallization as observed during the sintering process  where 
no crystallization peaks were identified at 540°C for S53B50 and P40B10 in contrast 
to the samples sintered without NH4(HCO3). This indicates that the scaffolds from 
these two compositions maintained their amorphous nature. 
Open porosity of more than 60% was achieved at 70 vol. % addition of NH4 (HCO3) 
and an average interconnected pore diameter in the range of 243.8 – 285.5 µm. As 
prepared, the S53B50 scaffold has a compressive strength of 1.29 ± 0.21 MPa, which 
decreased to 0.52 ± 0.3 MPa after immersion in SBF for 168 hours. In comparison, 
the as prepared P40B10 scaffolds had a compressive strength of 1.56 ± 0.63 MPa, 
which increased to 3.2 ± 0.38 after immersion for 168 hours in SBF while Sr had 
strength of 3.63 ± 0.69 MPa, which decreased to 1.52 ± 0.08 MPa after 168 hours 
immersion in SBF. These values were obtained at 60 vol. % content. After 168 hours 
in SBF, the weight loss of S53B50 and Sr was 6.36 ± 0.31 and 11.58 ± 0.38, 
respectively. This clearly indicates that Sr had a faster degradation rate. However, due 
to the acidic environment of the solution, the conversion rate to HA was inhibited. 
Similar behavior was observed for P40B10 but with slow degradation of the glass. 
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Despite the low weight loss of S53B50, which indicates a moderate degradation rate, 
S53B50 was found to have the fastest conversion rate to HA. 
These glass compositions, at the exception of the glass Sr, have shown to be 
promising in terms of apatite formation and can be successfully processed into porous 
scaffolds, while maintaining their amorphous nature, which are favorable for 
supporting tissue ingrowth.  
In addition, further work should be done to investigate the effects of SrAl2O4 
luminescent on the mechanical and in vitro properties of the glasses. 
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